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GENERAL INTRODUCTION
Cardiac dys- or arrhythmias are abnormalities of cardiac rhythm, reflecting
disturbances of either impulse initiation or impulse propagation, and frequently
resulting in a heart frequency either below or above the normal heart rate for the
patient’s age.
Frequency and clinical significance of arrhythmias are different in adults and
children.
Although cardiac arrhythmias are relatively infrequent in infants and children, it
is very important to recognise and manage basic arrhythmias, since symptoms
and complications of arrhythmias can be serious. With the continuing advances
in the surgical correction of congenital heart defects, the number of children with
complex arrhythmias continues to increase.
It is hard to say what the prevalence of cardiac arrhythmias in the paediatric
population is. Few large series exist and the incidence reported varies greatly.
Supraventricular tachycardia is the most common arrhythmia seen in children
and its occurrence is estimated at between 1 per 250 to 1 per 1000 children 1-4. In
children with congenital heart disease, especially when they have undergone heart
surgery, the incidence of arrhythmia increases with time.
In this thesis we will discuss different aspects of treatment of diverse
arrhythmias. In this regard, catheter therapy of some uncommon
arrhythmias will also be discussed. All studies in this thesis were approved
by the institutional review boards of the participating centers.
Normal heart rate varies with age: the younger the child the faster the heart rate.
Therefore the definitions of bradycardia (<60 beats/min) and tachycardia (>100
beats/min) used for adults, do not apply to infants and children. For children
tachycardia is defined as a heart rate beyond the upper limit of normal for
patient’s age and bradycardia is defined as a heart rate slower than the lower limit
of normal (Table).
TACHY-ARRHYTHMIAS
The mechanism of tachy-arrhythmias is based on either the existence of a re-
entry circuit, abnormal automaticity or triggered activity. The most common
mechanism in children is re-entry. To obtain a re-entry circuit, two major
conditions are necessary: the presence of a unidirectional block and an area of
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Table
Normal ranges of resting heart rate.
Age Beats/minute
New-born 110 - 150
2 year 85 - 125
4 year 75 - 115
Over 6 year 60 - 100
slow conduction, which delays the impulse long enough to allow the circuit ahead
to become excitable. Such a re-entry circuit may occur around an anatomical
obstacle like the AV node together with an accessory pathway between the atria
and ventricles, or with dual AV node physiology. A re-entry circuit may also be
due to changes in the conduction properties of cardiac tissue (figure).
Tachycardias caused by rapid firing of one or more foci due to abnormal
automaticity are relatively rare. The cellular mechanism that is involved is similar
to that which underlies the automaticity of pacemaker cells. In abnormal
automaticity, a non-automatic cell acquires diastolic depolarisation. These foci
can be situated in the atrial tissue or in the ventricles.
Arrhythmias arising from triggered activity are difficult to distinguish from those
induced by re-entry. Triggered activity is always coupled to the preceding action
potential and is caused by afterdepolarisations; early afterdepolarisations or late
afterdepolarisations.
Clinical arrhythmias however depend on multiple mechanisms. It must be taken
into account that apart from the arrhythmogenic substrate, also modulating
factors, particularly changes in the automatic nervous system, and the occurrence
of triggers are required to initiate and maintain arrhythmia (figure).
The commonest mode of presentation of arrhythmia in early infancy is with
heart failure. Many infants will tolerate a supraventricular tachycardia well for
about 12 to 24 hours. If the tachycardia is sustained for a longer period, some
infants may develop signs of cardiomyopathy and congestive heart failure. This is
not surprising, given the very rapid ventricular rate, the immaturity of the
myocardium at this age and the fact that tachycardia is usually not noticed unless
the baby is under observation for another reason.
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FIGURE.Drawing summarising the mechanism of tachy-arrhythmia caused by re-entry.
In A sinus rhythm is shown; the stimulus is generated from the sinus node (SN) and
conducted to the ventricle utilising the AV node (AVN) and an accessory connection
(AC). In B a stimulus is generated from an atrial extrasystole (AE) and is conducted to
the ventricle using solitarily the AVN. The AC is blocked antegradely (B), which
permits the occurrence of retrograde conduction of the same stimulus over the AC
from the ventricle back to the atrium in C. This beat is limited to one single echo beat
by the occurrence of antegrade block in the AVN (C). When this block in the AVN is
not present, re-entrant tachycardia occurs as shown in D. These four drawings also
show the relation between the several factors needed for occurrence of tachy-
arrhythmia; an arrhythmogenic substrate -the AC-, an initiating trigger -the AE- and
modulating factors -antegrade block in the AC in B and antegrade block in the AVN in C-.
The majority of older children with tachycardia present with palpitations and
sometimes with an observed irregularity of the pulse. Hemodynamic compromise
will result in symptoms like dizziness, near syncope or even syncope. A severe
tachycardia might cause sudden cardiac death, as sometimes occurs in patients
with long QT syndrome or in patients having undergone previous cardiac surgery
for congenital heart disease. Occasionally tachycardia presents with heart failure
and dilated cardiomyopathy in this older paediatric patient group.
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Management of tachyarrhythmia
In children presenting with a tachyarrhythmia episode for the first time, vagal
stimulation techniques like carotid sinus massage, eyeball compression, or
application of an icepack to the face (also termed the diving reflex) are tried to
terminate the arrhythmia. If vagal manoeuvres fail, the next step is to try an anti-
arrhythmic drug like adenosine (administered intravenously to acutely terminate
re-entrant arrhythmias involving participation of the AV node). In some cases
atrial overdrive pacing with a catheter in the oesophagus or right atrium might be
effective in discontinuing arrhythmia. Electrical cardioversion sometimes is
required for patients with sustained atrial flutter, ventricular tachycardia or
ventricular fibrillation.
As soon as the arrhythmia episode is over, recurrence of tachycardia is prevented
with a maintenance dose of anti-arrhythmic medication. It should be taken into
account that only limited knowledge exists regarding pharmacokinetics and
pharmacodynamics of the various anti-arrhythmic agents in newborns, infants
and children. To date, no antiarrhythmic agent has been specifically developed or
tested for use in infants and children. Relatively uniform guidelines for dosing in
paediatric practice, to ensure both efficacy and safety have been brought about by
the large volume of experience in children over the past years.
Spontaneous resolution of conduction through accessory pathways occurs in
nearly one-third of the affected children within 12 months of birth 5,6 and there
also seems to be a high rate of spontaneous disappearance for automatic atrial
tachycardia 7.  It is well recognised that tachyarrhythmias in young children show
a bimodal age distribution. There is an initial peak of incidence in the first year of
life, followed by a relatively symptom-free interval between 1 and 5 years of age.
Thereafter, these arrhythmias tend to recur, with a second peak progressing into
adult life 6,8. This is also borne out by the numerous published series on catheter
ablation, the majority of the procedures having been undertaken in young adults.
Radiofrequency catheter ablation
The basic concept of radiofrequency catheter ablation is the application of
unmodulated sinusoidal waveforms at a relatively high frequency (300-750 kHz)
via an intracardiac electrode catheter to achieve tissue heating, creating a thermal
injury. During an electrophysiology study, the exact mechanism of the
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tachyarrhythmia is determined and the arrhythmogenic substrate localised. The
delivery of well circumscribed lesions to a specific target results in tissue
destruction and loss of electrical conduction. This specific target can be an
accessory pathway, or the critical isthmus of an intra-atrial re-entry circuit. In the
latter, a number of consecutive radiofrequency energy lesions are applied to create
a line of bi-directional block between two natural anatomic barriers, bordering
the critical isthmus for the re-entry circuit. This line is unable to conduct
electrical pulses and will therefore eliminate the re-entry circuit, rendering the
tachycardia non-inducible. The first one to describe the use of radiofrequency
catheter ablation in an infant was van Hare in 1990 9. At the current time,
indications for ablation include failure of medical therapy, unacceptable side
effects of medical therapy, complications like tachycardia induced
cardiomyopathy, life threatening arrhythmias, or as an elective procedure
depending on patient and/or parental choice. Currently, general agreement on
indications for the performance of radiofrequency catheter ablation in children
exists in a NASPE position statement 8.
Usually the position of intracardiac catheter electrodes during
electrophysiological procedures is estimated from biplane fluoroscopic images.
With the current advanced techniques applied to ablate complex arrhythmia
substrates, the estimation of electrode positions allowed by this method is
imprecise and new mapping systems were developed.
LocaLisa mapping system
This mapping system (LocaLisa, Medtronic, Inc.) has the ability to determine
accurate three-dimensional localisation of intracardiac electrodes 10. The
localisation technique of LocaLisa uses three skin electrode pairs to send three
small currents through the chest in three orthogonal directions. A slightly
different frequency is used for each direction. In this way a constant voltage
gradient is created across the heart, which standard intracardiac catheter
electrodes can measure. The voltage at any given point is measured with reference
to a fixed intracardiac electrode. Automatically the 3 electrical field strengths are
calculated and by dividing each amplitude (V) by the corresponding electrical
field strength (V/cm) the position of any standard electrode can be determined in
3 directions. The LocaLisa mapping system has contributed significantly to
catheter ablation procedures for an extensive scala of arrhythmia in children. The
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mapping system allows a more aggressive approach for catheter ablation in this
particular patient group with small hearts, by enabling the location of the
ablation catheters to be more precisely monitored and the distance from the vital
conduction structures of the heart (like the His bundle) to be measured.
Electro-anatomical mapping system
This mapping technique (CARTO, Biosense Webster, Diamond Bar, CA) uses
three distinct low frequency electromagnetic fields, encompassing the volume of
the heart. Specially designed catheters are able to sense these calibrated magnetic
fields. By triangulation the exact catheter position can be accurately determined
in relation to the locations of the electromagnetic point sources 11. If a second
mapping catheter is inserted into a stable intracardiac position, this can be used
as a reference point, creating the ability to measure chamber volumes and
absolute and relative catheter tip locations in relation to this reference catheter. By
correlation of spatial coordinates and activation timing determined in reference
to a fixed cardiac electrical event, activation sequence maps can be reconstructed.
A visual representation of the mapped endocardial points is reconstructed and
onto this estimated endocardial surface continuous defined isochronal maps can
be displayed.
Post-ablation care
Although catheter manipulation in small hearts might be associated with greater
technical difficulty of the procedure when compared with adults, current reports
show low complication rates 12,13. Besides creation of complete heart block,
complications can include penetration of the myocardium, pericardial effusion,
valve damage and coronary arterial complications. In paediatric patients who
undergo catheter ablation, many centers often perform echocardiography before
and after the ablation procedure to assess these immediate potential subclinical
complications. The clinical value of this routinely performed echocardiography is
discussed in this thesis.
There also remain concerns about the long-term problems associated with
radiofrequency catheter ablation technique in the paediatric age group.
Recurrence of arrhythmia has been reported 12,13 and little data exist on the follow
up behaviour of radiofrequency ablation lesions in immature myocardium. For
these reasons it is critically important to continue performing long-term follow
up in this patient group.
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BRADY-ARRHYTHMIAS
Brady-arrrhythmia can be caused by sinus bradycardia, sinus pause, sinus arrest
and AV block.
In the sick sinus syndrome the sinus node fails to function as the dominant
pacemaker of the heart, resulting in the occurrence of a variety of arrhythmias,
bradycardic but also tachycardic. In occasional cases, sick sinus syndrome is
idiopathic, but for the majority this syndrome occurs after extensive cardiac
surgery, particularly if the atria are involved. An example of surgery, often
complicated by sick sinus syndrome is the Mustard or Senning procedure for
transposition of the great arteries, which is dealt with in chapter 8 of this thesis.
Another rare, and poorly understood condition is idiopathic silent atrium. In this
condition, there is electrical, and sometimes associated mechanical, atrial
standstill, as diagnosed by the absence of P-waves on the ECG. Although the
cause of silent atrium is often unknown, a familial form has been described, as
well as forms associated with systemic muscular dystrophy, myocardial
amyloidosis and myocarditis. Transient atrial standstill is often seen after cardiac
surgery or in reaction to anti-arrhythmic medication. While generally thought to
be progressive, some cases of spontaneous recovery of atrial function have been
documented. We report two children with idiopathic silent atrium, both of whom
developed intra-atrial re-entrant tachycardia, and required catheter ablation.
These patients are described in chapter 4 of this thesis.
When the atrioventricular (AV) node is non-functional, the normal sinus impulse
cannot be conducted to generate a ventricular response, which may cause
bradycardia. High degree AV block can be congenital or acquired. Congenital AV
block is strongly associated with maternal connective tissue disease such as
systemic lupus erythematosus and  Sjögren’s syndrome. It can also be associated
with structural heart disease. Cardiac surgery is the most common cause of
acquired complete heart block in children.
Complications that may occur from bradycardia are symptoms of hemodynamic
disturbance, like exercise intolerance, dizziness or syncope. Whether symptoms
occur, depends on the frequency of the nodal or ventricular escape rhythm.
Patients with congenital complete AV block are also described to be at long-term
risk to develop cardiomyopathy, resulting in congestive heart failure 14-17.
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Management of bradycardia
Permanent pacemaker therapy is indicated for symptomatic bradycardia and
complete heart block with low escape rhythms. A task force of the American
Heart Association, the American College of Cardiology and the North American
Society for Pacing and Electrophysiology has established guidelines for the
implantation of permanent pacemakers 18,19.
Over the past 20 years, remarkable technological advances have been made in
pacemaker design and function. The size of the pulse generator and leads have
decreased, allowing endocardial pacing, as it already was in adults, to be the
preferred route in children also. In contrast with adults, children are subjected to
somatic growth, with possible lead tension and the need for lead replacements
and lead extractions. Greater technical difficulty associated with the patient’s size,
the risk of venous occlusion and skin erosion at the generator site are other
concerns that make most paediatric centers still advocate the epicardial approach
in children.
DYSRHYTHMIAS POST-SURGERY
Although the prognosis for patients with congenital heart defects has improved
by surgical treatment, they remain at a well-recognized risk for late
complications. As discussed previously in this introduction, arrhythmias are likely
to occur after cardiac surgery. In addition, the hemodynamic consequences of
arrhythmia associated with structural heart disease may be more profound in
these patients, than in those with a normal heart.
Besides early post-operative arrhythmias like complete heart block or direct
damage to the sinus node, arrhythmia can also arise as a late complication of
surgery. Particularly if surgery involves parts of the atria, patients are prone to
develop late arrhythmia and many will lose sinus rhythm in follow up. Patients
who have lost sinus rhythm are also prone to develop other arrhythmia like the
previously described dangerous bradycardia-tachycardia (sick sinus) syndrome.
Apart from damage to the sinus node, these patients also usually have numerous
sutures and sometimes prosthetic material in the atria. These surgical scars form
areas of slow conduction, creating a substrate for scar related re-entry, the
mechanism responsible for incisional atrial tachycardia. A good success rate for
radiofrequency catheter ablation of incisional atrial tachycardia is described 20,21.
Lines of block were created by radiofrequency current application between scars
and natural anatomic barriers, or between two scars, closing the isthmuses that
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were demonstrated to be critical for the re-entrant circuit. The use of a mapping
system like LocaLisa or Carto has been of great use in facilitating these
procedures 20-22.
Unfortunately, also sudden cardiac death remains a worrisome complication of
surgery for congenital heart defects 23,24. Silka described in 1998 that the risk of
late sudden death for patients surviving an operation for a common congenital
cardiac defect is 25 to 100 times greater than in an age-matched control
population 23. The majority of these sudden deaths occurred in patients with
aortic stenosis, coarctation,  tetralogy of Fallot or transposition of the great
arteries. Most but not all sudden cardiac deaths were presumably due to
arrhythmogenic causes.
The incidence of sudden cardiac death in patients having undergone a Mustard
or Senning procedure for transposition of the great arteries is reported to be
between 2 and 15%. The final chapter of this thesis discusses whether there are
any identifiable predictors for sudden cardiac death in patients with transposition
of the great arteries, who have survived a Mustard or Senning operation.
AIM OF THE THESIS
The studies in this thesis describe the follow-up of paediatric patients having
undergone treatment for different types of arrhythmia. In this respect we
concentrated on radiofrequency catheter ablation and transvenous pacemaker
implantation. We investigated safety, efficacy and outcome of these treatment
options for several different arrhythmias. Special attention is being paid to the
advances of new developed mapping systems on radiofrequency catheter ablation
of the more challenging arrhythmia substrates.
In addition we have attempted to identify predictors of sudden cardiac death in
patients who have survived Mustard’s or Senning’s operation for transposition of
the great arteries.
OUTLINE OF THE THESIS
In chapter 2 the efficacy and safety of radiofrequency catheter ablation in children
18 years or less are described. The clinical outcome, complication- and recurrence
rate for different types of arrhythmias were evaluated for sixty-four patients
having undergone radiofrequency catheter ablation in a Dutch university
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hospital. After each ablation procedure, routine echocardiography was performed
in each patient to assess eventual asymptomatic complications of the ablation
procedure. In chapter 3 we evaluated the clinical importance of echocardiography
performed routinely in all paediatric patients at two institutions after
radiofrequency ablation for supraventricular tachycardia.
Chapter 4 deals with idiopathic silent atrium, which is a poorly understood
condition. Management and outcome of intra-atrial re-entrant tachycardia
occurring in two patients with a co-existing silent atrium are described.
Another rare form of arrhythmia is non-automatic focal atrial tachycardia, an
arrhythmia diagnosed when a patient had focal atrial tachycardia, which was
inducible with pacing manoeuvres in the electrophysiology laboratory. We
investigated the arrhythmia characteristics of non-automatic focal atrial
tachycardia in chapter 5. In addition the ablation results for this arrhythmia with
fluoroscopy guided catheter manipulation were compared to those with the use
of electro-anatomical mapping (Carto) in an American university hospital.
The contribution of the LocaLisa mapping system to the safety and efficacy of
radiofrequency catheter ablation of atrioventricular nodal re-entrant tachycardia
in children is described in chapter 6.
In chapter 7 is dealt with treatment for bradycardia in the form of pacemaker
implantation. The outcome of transvenous pacemaker implantation in children
with low bodyweights is studied, since problems of endocardial pacing are
expected to occur in this patient group. To obtain a larger study population, the
experience with endocardial permanent pacing was combined for two
institutions.
Patients, who underwent an atrial switch for transposition of the great arteries in
childhood, are known to be prone to several late complications. Besides right
ventricular failure and the occurrence of late arrhythmia, sudden cardiac death is
one of the most worrisome late complications of physiologic repair. In chapter 8
we have attempted to identify predictors for sudden cardiac death after the
Mustard or Senning operation for transposition of the great arteries.
The thesis concludes with a general summary and discussion in English and
Dutch.
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ABSTRACT
Background
In adults, radiofrequency (RF) catheter ablation has already been established to
be safe and effective fro a variety of arrhythmia substrates. The procedure has
also been shown to be effective in infants and children.
Methods/results
Radiofrequency catheter ablation was performed in 64 patients, aged 18 years
or less. Out of  38 patients with one or more accessory pathways, ablation was
successful during a single session in 34 patients, while 4 patients required
additional sessions. Atrioventricular reentrant tachycardia (AVNRT) was found
in 14 patients and ablation was successful in 13 of these. No conduction
disturbances were observed.  Five patients had ventricular tachycardia (VT),
one right-sided and four left-sided. In one patient, VT could not be induced. In
the remaining four patients, VT was abolished. Finally seven patients had atrial
tachyarrhythmia, which was focal in two and reentrant in five. Ablation was
successful in six out of seven patients; in one patient the tachyarrhythmia could
not be induced.
Conclusion
Catheter ablation in children is a highly successful definitive therapy for most
forms of tachyarrhythmia
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INTRODUCTION
In adults radiofrequency (RF) catheter ablation has already been established to be
safe and effective for a variety of tachyarrhythmia substrates. The procedure has
also been shown to be effective in infants and children 1-5. However, the technical
difficulties associated with manipulating catheters in small hearts, concerns about
an increased risk of complications and about potential growth of the RF lesion
with somatic growth have all contributed to the limited use of this approach in
paediatric practice. We report our experience with RF catheter ablation treatment
of different tachyarrhythmias in children under 18 years of age.
PATIENTS AND METHODS
In the period from January 1996 to March 2000, 64 patients, aged 18 years or less,
underwent 76 RF ablation procedures for different tachyarrhythmia substrates.
There were 31 male and 33 female patients with a median age of 15 years (range 3
weeks – 18 years). In 57% of patients the indication for RF ablation was failure of
medical therapy using up to two antiarrhythmic drugs. Failure was defined as
documented recurrence of the clinical tachyarrhythmia within a six-month
period after commencement of medical therapy, despite an adequate drug dosage
adjusted for body weight. In 12% pharmacological therapy was associated with
unacceptable side effects. In 25% of patients, elective RF catheter ablation was
undertaken instead of commencing antiarrhythmic medications. Finally, in 6% of
patients, the indication for RF ablation was severe tachycardia-induced
cardiomyopathy (one patient) or life-threatening tachyarrhythmias (three
patients).
Technique
Electrophysiological studies were performed under general anaesthesia in the
majority of patients. Electrode catheters were introduced via the femoral or
internal jugular venous approach to the following positions: right atrial
appendage, His’ bundle area, right ventricle and coronary sinus. In selected
patients with intra-atrial reentrant tachycardias, a 20 polar halo catheter was
used. For left sided accessory pathways, the transseptal approach was preferred.
Standard stimulation and mapping techniques were used to identify the
mechanism of the tachyarrhythmia, and the location of accessory pathways. In
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patients without manifest preexcitation, tachyarrhythmia induction was
performed by various pacing techniques, with intravenous isoprenaline infusion
if required. After the diagnosis was established, ablation was performed. Catheter
manipulation was guided by fluoroscopy, and since January 1997 by the Localisa
system, a novel mapping system developed at our institution which allows precise
3-dimensional localization of standard intracardiac electrodes 6.
Treatment success
Success was defined for each arrhythmia substrate as follows:
- accessory pathways: absence of accessory pathway conduction in both
directions, antegrade and retrograde, using pacing and extrastimulus
techniques;
- AV nodal reentrant tachycardia: absence of dual AV node physiology following
slow pathway ablation;
- Intra atrial re-entry tachycardia (IART) and incisional tachycardia:
confirmation of bi-directional block across the line of block created between
two natural anatomic barriers or scars.
- Ventricular tachycardia (VT) and ectopic atrial tachycardia (EAT): absence of
spontaneous ectopy, and non-inducibility of the clinical tachyarrhythmia.
RESULTS
Arrhythmia substrates
Thirty-eight patients had atrioventricular reentrant tachycardia mediated by one
(31 patients) or multiple (seven patients) accessory pathways. Fourteen patients
had atrioventricular nodal reentrant tachycardia (AVNRT), five patients had
ventricular tachycardia (VT), two patients had ectopic atrial tachycardia, and five
patients had intra-atrial reentrant tachycardia. Table 1 summarizes the patient
data.
Accessory pathway ablation
In 38 patients 47 accessory pathways were identified. All pathways were
successfully ablated. One patient with a right free wall pathway and two patients
with a septal pathway required two ablation sessions. One patient with two
Mahaim pathways, one concealed bypass and AVNRT required four sessions. In
all other patients successful ablation was accomplished  in a single session.
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Two patients had permanent junctional reciprocating tachycardia (PJRT). Both
developed tachycardia-induced cardiomyopathy in early infancy, despite
treatment with several antiarrhythmic medications. Ablation of a slowly
conducting right sided posteroseptal pathway with decremental properties was
successfully performed at three weeks and five months respectively. Successful
ablation was associated with rapid recovery of myocardial function. Both patients
were symptom-free and without antiarrhythmic medications at a follow-up of
three years and six months respectively.
AV node modification for AV node reentrant tachycardia
Four-teen patients diagnosed as having AV node reentrant tachycardia underwent
slow pathway ablation. An anatomical approach was used to target the slow
pathway. The end-point for the procedure in 13/14 patients was absence of dual
AV physiology. In one six year old girl, the end-point for the procedure was non-
inducibility of AV nodal reentrant tachycardia, but with dual AV physiology still
Table 1.
Ablation Results
Substrate patients (n) age procedures success follow-up
(median [range], (n) (n) (median [range],
years)  years)
Accessory Pathway 38 13.9 (0.1-17.1) 44 38(100%)# 1.9 (0.2-3.8)
Single 31 34 31
- left free wall 20 20 20
- right free wall 4 5 4
- septal 5 7 6
- PJRT 2 2 2
Multiple 7 10 * 7
AVNRT 14 15.6 (6.4-17.6) 14 13 (93%) 2.1 (0.1-4.0)
VT 5 14.2 (8.8-16.7) 7 3 (60%) 1.7(0.3-3.3)
- LV 4 5 2
- ARVD 1 2 1
Atrial tachycardia
- focal 2 14.8 & 15.3 2 1 (50%) 0.8 & 1.4
- macro-reentrant 5 9.5 (2.9-17.9) 6 5 (100%) 1.3(0.5 –3.3)
PJRT=permanent junctional reciprocating tachycardia; AVNRT=atrioventricular nodal reentrant tachycardia;
VT=ventricular tachycardia; LV=left ventricular; ARVD=arrhythmogenic right ventricular dysplasia. Age and
follow-up are expressed as median and range. # One patient had a late recurrence (2 years post-ablation) of
conduction via a posteroseptal accessory pathway (see text). * One patient with multiple pathways required 4
sessions, the remaining six underwent a single session.
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being present. She has since had a recurrence of her clinical tachyarrhythmia two
weeks after the RF ablation procedure, and is awaiting a second procedure. For
the entire group, the median follow-up is 2.1 years (range 0.1 to 3.8 years);  13
patients remained free of tachycardia without antiarrhythmic medication. No
patient developed conduction disturbances after the ablation.
Ablation of ventricular tachycardia
Five patients were diagnosed to have ventricular tachycardia (VT). One patient
with arrhythmogenic right ventricular dysplasia underwent successful ablation of
two tachycardia circuits during two separate procedures. The other four patients
had a fascicular left ventricular tachycardia. Ablation was successful in two
patients. In one patient, ablation could not be performed as the tachyarrhythmia
was not inducible despite an aggressive extrastimulus protocol with isoprenaline
infusion. The remaining patient, a 13 year old girl had been admitted to her local
hospital with a short history of palpitations and syncope. A fascicular left
ventricular tachycardia was diagnosed. Echocardiography showed a dilated left
ventricle with impaired function, and the clinical picture was interpreted as
tachycardia-induced cardiomyopathy. She had required cardiopulmonary
resuscitation on three occasions prior to transfer to our hospital. The
tachyarrhythmia was transiently responsive to verapamil. In view of the life-
threatening presentation, emergency ablation of the tachyarrhythmia was
undertaken over two sessions, each lasting six hours. The fascicular tachycardia
was rendered non-inducible. The low cardiac output state was managed with
intravenous inotropic medications including dopamine, milrinone and
norardenaline. Following recurrent episodes of polymorphic ventricular
tachycardia, for which DC cardioversion was required, she was treated with a
continuous infusion of intravenous amiodarone. Finally two days post-ablation
she developed intractable polymorphic ventricular tachycardia and could not be
resuscitated. Autopsy demonstrated severe dilated cardiomyopathy with global
myocardial necrosis, suggesting a pre-existent viral myocarditis.
Ablation of ectopic atrial tachycardia
In two patients ectopic atrial tachycardia was diagnosed.  Ablation was successful
in one patient. In the second patient, the tachyarrhythmia was not inducible
under general anaesthesia. A second ablation procedure under local anaesthesia
was undertaken, but the tachyarrhythmia could not be induced during the
electrophysiology study. The procedure was therefore abandoned.
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Ablation of intra-atrial reentrant tachycardia
Five patients were diagnosed to have intra-atrial reentrant tachycardia (IART).
The first two had previously undergone repair of a congenital heart defect
(closure of secundum atrial septal defect, and an atriopulmonary Fontan
connection for tricuspid atresia). Reentrant circuits related to the surgical scars
were identified during the electrophysiology study in these patients. Lines of
block were created by application of RF energy between the scars and natural
anatomic barriers to abolish the tachycardia circuit.
The third patient presented with congenital complete AV block, and underwent
transvenous dual chamber pacemaker implantation at six years of age. At routine
follow-up she was noted to have IART. At electrophysiology, common atrial
flutter was inducible. Isthmus block was created between the tricuspid annulus
and inferior vena cava. However, IART remained inducible at the end of the
procedure, and clinical recurrences were documented at follow-up. During a
second procedure, a  macro reentrant circuit was mapped on the right atrial free
wall, within areas of atrial electrical silence. She underwent successful ablation of
this circuit, by creation of a line of block to the inferior vena cava.
The fourth patient with IART presented at 14 months with atrial flutter.
Following antiarrhythmic therapy she developed progressive sinus node
dysfunction and AV block, for which a dual chamber epicardial pacemaker was
implanted elsewhere. At serial follow-up she developed silent atrium and had a
cerebrovascular accident. Thereafter, she was referred to our institution. On
discontinuing the antiarrhythmic medications, atrial electrical activity was
restored, and common atrial flutter recurred. This was successfully ablated.
The fifth patient had previously undergone surgical closure of  a secundum atrial
septal defect. At electrophysiological study, she had  typical atrial flutter. In
addition, she had a scar-related IART and uncommon AV nodal reentrant
tachycardia. All tachyarrhythmia substrates were successfully ablated during a
single session.
Fluoroscopy and procedure times
The average fluroscopy time was 16.5 ± 12 minutes. The procedure time was on
average two hours, for a single accessory pathway or for modification of AV nodal
reentrant tachycardia. For complicated arrhythmia substrates, such as intraatrial
reentrant tachycardia, the mean fluroscopy time was 28.4± 13.8 minutes.
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Complications
Procedure-related complications occurred in two patients. One patient had a
posteroseptal and a para-Hisian pathway. He had incessant orthodromic
reciprocating tachycardia and interruption of the posteroseptal pathway did not
abolish the tachyarrhythmia. Therefore, a decision was made to ablate the para-
Hisian pathway as well. This was complicated by complete AV block. A
transvenous dual chamber pacemaker was implanted prior to discharge from
hospital. Two years later, at routine follow-up, the patient was noted to have 1:1
AV conduction via the posteroseptal pathway. He did not, however, have
tachyarrhythmia. The second complication occurred in a 13-year-old girl,  who
died two days following ablation of a fascicular ventricular tachycardia, as
previously described.
Follow-up
All patients have been followed up serially in the outpatient clinic. Routine
investigations at follow-up included physical examination, 12 lead ECG and
echocardiography to document normalization of ventricular function. In patients
with persistent symptoms such as palpitations, 24 hour Holter recordings and
ambulatory patient-operated Holter recordings were performed to confirm that
there was no recurrence of the tachyarrhythmia.
DISCUSSION
The first reported application of RF catheter ablation in a child was in 1990 in a
10-month-old baby with junctional ectopic tachycardia 7. Since then other reports
on RF catheter ablation in children have been published, describing its
effectiveness in the non-pharmacological  therapy of tachyarrhythmias. Concerns
about RF ablation in children have also been reported. Lower patient weight (and
thus younger patient age) were associated with a higher incidence of procedure-
related complications in the earlier series 3. These technical limitations have
largely been overcome with improved catheter technology and better algorithms
for diagnosing the location of accessory pathways from the surface ECG. These
have contributed to shortening of the procedure time and improved safety. In our
own series, there was one episode of complete AV block following ablation of a
para-Hisian pathway. Despite good results at short-term follow-up, data for the
long-term are not yet available. Consequently little can be said about the possible
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deleterious effects of scars on the myocardium in the pediatric age group. RF
lesions in lambs appear to grow with time and infiltrate into the normal adjacent
myocardium 8. Conversely this does not occur with RF lesions in adult canine
myocardium 9 or in young pigs 10. The only study  performed in children did not
report any increase in lesion size at follow-up 11. We are aware that our follow-up
time is indeed short. This limitation is a reflection of the fact that RF ablation
therapy has been applied to children very recently. The theoretical risk indeed
exists that these RF lesions could grow and may themselves become
arrhythmogenic in future. Careful long-term follow-up is therefore indicated.
Growing experience seems to be associated with higher success rates, shorter
fluoroscopy time and a lower complication rate 3. At our center, adult and
pediatric ablation procedures are performed by the same team, resulting in a large
patient volume. In addition, a non-fluoroscopic mapping system LocaLisa is used
to precisely determine the position of intracardiac electrodes. This allows for
accurate mapping and measurement of distances to critical structures such as the
His’ Bundle.
Many different opinions about indications for RF catheter ablation in children
exist among paediatric cardiologists. Some recommend the procedure as the
treatment of choice even in children with infrequent self-terminating
arrhythmias. Others will not recommend the procedure until life-threatening
symptoms due to the tachyarrhythmia develop 12. In general, drug failure or life-
threatening arrhythmias are accepted indications for ablation.
Perry et al. described 60 patients with WPW syndrome whose tachycardia
occurred for the first time at between zero and two months after birth. In 93% of
these patients supraventricular tachycardia did not recur by eight months of age.
However, 31% of patients had a recurrence of tachyarrhythmia at an average age
of eight years. Additionally, if tachycardia was present above five years of age, it
was persistent in 78% of these patients at a mean follow up interval of seven years 13.
This suggests that there is a bimodal age distribution in the occurrence of
symptomatic episodes of supraventricular tachycardia, with many children
remaining symptom-free between the ages of one and five years. Since RF
ablation therapy has become accepted, the majority of arrhythmias that have been
cured in the large series reported in the adult literature, are reentrant
supraventricular tachycardia due to a manifest or concealed accessory pathways.
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This suggests that the congenital accessory connections remain potentially active
for the rest of the patient’s life, and account for symptoms in adult life requiring
ablation therapy.
The frequency of symptoms with medication and life-threatening symptoms, i.e.
tachyarrhythmia induced cardiomyopathy, are two important considerations to
ablate tachyarrhythmia substrates in children. Increasingly, the good results with
this approach means that ablation therapy can also be offered electively to older
children, with minimal risks. The low complication rate combined with the high
success rate make catheter ablation an attractive alternative to long-term drug
treatment.  The majority of paediatric series on RF ablation therapy (including
our own) deal with older children. This in turn reflects the fact that RF ablation
therapy in children is a relatively recent development. In infants, RF ablation
should be reserved for patients with life-threatening arrhythmias with myocardial
dysfunction.
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ABSTRACT
Aims
Although the complication rate of radiofrequency catheter ablation (RFCA)
procedures in children is low, clinically asymptomatic complications do
occur. We determined the clinical value of routine transthoracic
echocardiography (TTE) performed after catheter ablation of
supraventricular tachycardia (SVT) in children.
Methods and Results
Between April 1996 and September 2001, 138 children (75M, 63F), (mean
age 13 years; range 0-19 years), underwent 160 uncomplicated
radiofrequency catheter ablation (RFCA) procedures for SVT at our two
institutions. In every child a TTE with Doppler was performed before and
after the procedure.  The pre-ablation TTEs in all cases were normal.
Post ablation, in 4 clinically asymptomatic patients the TTE showed a
disorder: one patient with focal atrial tachycardia, ablated via a retrograde
aortic approach, had mild aortic valve insufficiency. This had resolved 6
months later. Three other children developed an asymptomatic pericardial
effusion. In 2 patients this resolved spontaneously; one patient required
pericardiocentesis. This same patient also developed a clinically
asymptomatic mild aortic insufficiency, which resolved spontaneously
within 6 months.
Conclusion
TTE after uncomplicated RFCA procedures in children is probably not
indicated children with structurally normal hearts, but has a role after
ablation procedures where the retrograde aortic approach has been used.
Routine echocardiography valuable after catheter ablation ?
31
INTRODUCTION
Radiofrequency catheter ablation (RFCA) has been performed in children for
about 10 years with good success rates and low overall complication rates 1,2.
Potential complications of RFCA include pericardial effusion and valve
damage which may be asymptomatic and can be detected by
echocardiography. However the likelihood of such complications is low 1,2. In
a prior study in adults, Pires et al noted a low value for a routine post-
procedure cardiac echo 3. There is no report on the role of routine
echocardiography after RFCA in children.
PATIENTS AND METHODS
Between April 1996 and September 2001, 138 children (75 male, 63 female)
with a structurally normal heart who had undergone  160 RFCA procedures
for supraventricular tachycardia were retrospectively studied. Their mean age
was 13 years (range 0 to 19). In every child a transthoracic 2-D
echocardiogram (TTE) with Doppler was performed before and after the
procedure. The following echocardiographic indices were documented in all
patients: whether the heart was structurally normal, inflow and outflow
velocities through all the cardiac valves, the presence or absence of valvar
insufficiency, global ventricular function assessed by M-mode measurement of
left ventricular fractional shortening, the presence or absence of regional wall
motion abnormalities assessed in short and long axis views, and the presence
or absence of pericardial effusion. Included in this study were children who
had undergone an uncomplicated RFCA procedure for supraventricular
tachycardia such as atrioventricular reentrant tachycardia due to an accessory
pathway (including Wolff-Parkinson-White syndrome and persistent
junctional reciprocating tachycardia) and atrio-ventricular nodal reentrant
tachycardia. We excluded children with congenital heart disease and complex
arrhythmias such as scar-related reentry and atrial flutter. The arrhythmia
substrates are shown in table 1. Except for one, none of the patients had any
clinically documented complications during the ablation procedure itself. This
single patient was found to have two accessory pathways, one postero-septal
and one para-Hisian. Since ablation of the postero-septal bypass tract did not
eliminate the arrhythmia, it was decided to also ablate the para-Hisian
pathway. This was complicated by complete AV block and the patient
underwent implantation of a transvenous pacemaker.
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Table 1.
Arrhythmia substrates.
Diagnosis n
AVNRT      42
Wolff-Parkinson-White syndrome      48
Concealed accessory pathway      41
Non-automatic focal atrial tachycardia        3
PJRT        2
Sinus node reentry        1
Junctional tachycardia        1
Abbreviations:  AVNRT: atrio-ventricular nodal reentrant tachycardia; PJRT: persistent junctional
reciprocating tachycardia.
RESULTS
Pre-ablation
All children had a structurally normal heart.  No single TTE performed before
the ablation procedure showed abnormalities.
Post-ablation
The echocardiograms following 156 out of 160 RFCA procedures were
considered to be normal. In four asymptomatic cases the TTE did show a
disorder as follows:
One 15 year old patient showed mild aortic valve insufficiency after an
ablation procedure for focal left atrial tachycardia. In this patient a retrograde
catheter approach via the femoral artery was used. The insufficiency had
resolved spontaneously 6 months later. Three other children had developed an
asymptomatic pericardial effusion. In two of those, (an 11 year old, who had
undergone successful ablation of a concealed left sided accessory bypass via a
trans-septal approach and a 16 year old, who had had a successful slow
pathway AV node modification) the pericardial effusion resolved
spontaneously. The third patient, 9 years of age, had a concealed left lateral
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bypass ablated via a retrograde approach. TTE showed a moderate sized
hemorraghic pericardial effusion requiring pericardiocentesis. This same nine-
year-old also developed a clinically asymptomatic mild aortic insufficiency,
which resolved spontaneously by 6 months.
DISCUSSION
Our study shows that routine TTE may occasionally detect problems in
otherwise asymptomatic patients. Although limited by the retrospective nature
of our study, we did not find abnormalities in either left ventricular function
or wall motion. We showed one patient with mild aortic valve insufficiency
and three patients with pericardial effusion. The mechanisms of postablation
pericardial effusion are unclear. However tissue trauma that results from
catheter manipulation and transmural lesions could induce a pericardial
effusion by inflammation of the visceral pericardium. Secondly, due to the
small size of catheters used in electrophysiologic studies, perforation may go
potentially unrecognized during the procedure, which also results in
pericardial effusion.
Damage to the valvular apparatus secondary to catheter trauma has been well
recognized 3-5. Injury to the aortic as well as the mitral and tricuspid valves
have been previously reported 3-5. We only noted injury to the aortic valve.
Previous reports suggest this complication occurs in about 1.1 % of patients
having ablation on the left side of the heart using retrograde approach 4.
However for the same catheter aproach, this incidence might rise to values up
to 30% in children and adolescents 5. Manipulation as well as prolonged
placement of a catheter across the valve leaflets may stretch and compress the
leaflets and subsequently damage them. However, Pires et al. could not find a
clear relationship between the valvular injury and technique of ablation.  In
their study, 9 patients had new onset aortic regurgitation post ablation when in
fact 8 of the 9 did not have transaortic valve catheter manipulation performed
during their procedure 3.   This raises important questions about the cause of
aortic regurgitation observed after catheter ablation procedures, and suggests
that trauma to the aortic valve may not be the only explanation.
A limitation of this study was that data were obtained retrospectively. Also
TTE’s were performed and interpreted by different echocardiographers at two
different laboratories.   However, the TTEs were done in a standard fashion.
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An important aspect of current management is that in most patients, catheter
ablation is now performed as a same day procedure. Several institutions allow
uncomplicated patients to go home on the same day after the procedure. In
view of this we have utilized routine TTE as a tool to assess potential
complications prior to discharge of the patient. Our above experience
demonstrates that routine TTE is probably not indicated in children with
structurally normal hearts undergoing catheter ablation for reentrant
atrioventricular tachyarrhythmias. The exception to this may be patients
undergoing retrograde ablation via the aortic valve, in whom it may be
advisable to assess aortic valve function, especially the presence of aortic
insufficiency, prior to discharge from hospital.
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SUMMARY
Two children with silent atrium and recurrent intraatrial reentrant
tachycardia (IART) are described. Patient 1 developed silent atrium
following antiarrhythmic medical therapy. On stopping medications,
spontaneous electrical activity returned as did the tachyarrhythmia. At
electrophysiological study,   areas of both atria were electrically silent
despite presence of P waves on the surface ECG. A common atrial flutter
circuit was successfully ablated. Patient 2 presented with congenital
atrioventricular block, and a transvenous dual chamber pacemaker was
implanted at 6 years of age. Thereafter she developed recurrent IART.  At 2
separate electrophysiologic studies, common atrial flutter and a
microreentrant circuit in the right atrium were ablated. During both
electrophysiological studies, silent areas were recorded in the right atrium.
The natural history of silent atrium presenting in childhood is unknown.
The possibility of spontaneous recovery of atrial function argues for
conservative treatment, such as ablation of the tachyarrhythmia rather than
His bundle ablation.
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Silent atrium (SA) is a syndrome characterised by quiescent atria which cannot
be activated by external electrical stimulation.1 This rare arrhythmia usually
presents with junctional bradycardia without any P-wave on the surface
electrocardiogram. The cause of SA is often unknown; permanent forms are
reported in patients with systemic muscular dystrophy, myocardial
amyloidosis and myocarditis.2 A transient form of SA is seen in reaction to
antiarrhythmic medication or after cardiac surgery. A familial form has also
been described.3 Besides bradycardia, atrial flutter can coexist in a partially
silent atrium.4 We here describe 2 children with SA and a coexistent intraatrial
reentrant tachycardia (IART) leading to symptoms of heart failure. Both
underwent successful ablation of their IART circuit.
CASE REPORTS
Patient 1
The first patient presented at 14 months with IART. She was treated with
sotalol (upto 8 mg/kg/day) and thereafter propafenone (upto 10mg/kg/day),
without adequate control of the tachyarrhythmia. The IART was successfully
converted to sinus rhythm by DC cardioversion. The subsequent ECGs
however showed frequent sinus arrest and ventricular standstill for three
seconds, for which a dual chamber epicardial pacemaker was implanted. Four
months later, IART recurred, and was not controlled with increased dosages of
sotalol. Electrical and mechanical silence of the atrium developed,
necessitating reprogramming of the pacemaker to VVI-R mode. She had a
cerebral infarction probably resulting from a thrombo-embolism arising from
the left atrium, leading to a left-sided hemiparesis. Thereafter, she was referred
to our institution. Treatment was commenced with oral anticoagulants. On
discontinuing the antiarrhythmic medications, atrial electrical activity on the
surface ECG was restored two months later, associated with recurrence of
IART. Echocardiography showed a dilated left ventricle with a fractional
shortening of 24%.
At electrophysiological study, although P waves seen on the surface ECG, areas
of electrical silence were recorded in both atria, despite having stopped
medications three months previously. A broad QRS complex tachycardia
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FIGURE 1. Spontaneous IART in patient 1, with a right bundle branch block
morphology of the QRS complexes. A classical flutter circuit with anticlockwise
activation of the atrium is seen from the endocardial recordings in the 20 polar halo
catheter (TA1 to TA10).
(fig.1) was initiated (rate 240/min). The entire tricuspid valve annulus was
mapped using a 20 polar halo catheter introduced from the inferior vena cava
and a 10 polar catheter introduced from the superior vena cava (fig.2). The
endocardial activation sequence confirmed an isthmus-dependent IART
circuit. A line of block was created by a series of radiofrequency current
applications, between the tricuspid annulus and inferior vena cava, terminating
the IART (fig.2). Bi-directional conduction block was confirmed by pacing on
either side of the line of block. One week post-ablation the ventricular
function had improved, with a left ventricular fractional shortening of 35%.
At follow-up three months later, she remained without symptoms, and with a
predominantly paced atrial rhythm.
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FIGURE 2. A left anterior oblique radiographic projection showing the location of the
20 polar halo catheter (large arrow) introduced via the femoral vein, and a 10 polar
catheter (double arrows) introduced from the internal jugular vein. Together, these
catheters enable mapping of the entire tricuspid valve annulus and isthmus.  The
ablation catheter (Abl) is located in the isthmus.
Patient 2
The second patient presented with congenital complete atrioventricular block
(SLE positive mother), and underwent transvenous dual chamber pacemaker
at 6 years of age. At routine follow-up, she was noted to have IART. This was
initially terminated by overdrive pacing using her own internal pacemaker
leads. Due to frequent recurrences (upto 25% of the time), it was decided to
undertake ablation of the IART circuit. At electrophysiological study, common
atrial flutter was inducible. Areas of electrical silence were recorded within the
right atrium. Isthmus block was created between the tricuspid annulus and
inferior vena cava, as described for patient 1. Despite this, IART remained
inducible. In view of the prolonged duration,  it was decided to terminate the
procedure.
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Four months post-ablation the patient returned with impaired ventricular
function (left ventricular fractional shortening of 17%), associated with a
recurrence of IART which required DC cardioversion. She underwent a
second electrophysiological study. During this procedure, a micro reentrant
circuit was mapped on the right atrial free wall. Areas of electrical silence were
still recorded from the right atrium. The line of block created during the first
electrophysiological study was noted to be complete in both directions. She
underwent ablation of this micro reentrant circuit, by creation of a line of
block to the inferior vena cava using a series of radiofrequency current
applications. Following the procedure, no tachyarrhythmia was inducible.
Over a follow-up of three months, she has had no recurrence of
tachyarrhythmia, and the ventricular function has improved  (left ventricular
fractional shortening of 25%).
DISCUSSION
Silent atrium is a poorly understood condition. There is little literature about
this in the paediatric population. It may be progressive in adults, with
diminution of P wave amplitude followed by complete disappearance of the P
wave over several years 5.  In our first patient, silent atrium developed during
treatment with high doses of antiarrhythmic medications. On discontinuation
of pharmacologic therapy, the surface P wave returned, suggesting an
association with  antiarrhythmic medical therapy. However, during
electrophysiological study, areas of atrial silence were present three months
after discontinuing all antiarrhythmic medications. This suggests that there
may be an ongoing pathological process in the atria. At follow-up after
catheter ablation, her atrial electrical activity is predominantly paced,
suggesting persistent sinus node dysfunction.
Patient 2 presented with congenital atrioventricular block. Clinical symptoms
arose only after dual chamber pacemaker implantation allowed for 1:1
atrioventricular conduction. She did not receive any antiarrhythmic
medications prior to catheter ablation. During the electrophysiological study,
areas of electrical silence were recorded in the right atrium, suggesting a
diffuse atrial disease process. An autoimmune process, which may also have
contributed to the atrioventricular block, cannot be excluded as the cause of
the electrical disturbances in the atrium.
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Balaji et al have described a patient with SA and coexistent atrial flutter who
was treated by His-bundle ablation 4. There is no literature about long-term
follow up of SA in children. Sporadic case reports with recovery of atrial
activity seen in infants suggest that SA does not have to be progressive in the
paediatric age group 6,7.  In view of this, destructive procedures such as His
bundle ablation should probably be avoided. In our two patients the IART
circuit, and a separate micro reentrant circuit in the right atrium were
successfully ablated. Both patients however still have areas of atrial electrical
silence, and it is unknown whether these areas will form the substrate for a
new IART circuit in the future.
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ABSTRACT
Non-automatic focal atrial tachycardia (NAFAT) is a rare and poorly
understood arrhythmia either due to microreentry or triggered mechanism.
NAFAT was defined as a focal atrial tachycardia which was inducible with
pacing maneuvers in the electrophysiology (EP) lab. We reviewed the charts
and EP study reports of all 38 patients with NAFAT, who underwent an EP
study at our center between April 1994 and September 2000. Patients were
predominantly female (n=31, 82%), aged 11-78 years (median 46). The mean
age at presentation was 31 years (range 7-71 years). None of the patients had
structural heart disease or had undergone prior heart surgery.
Electroanatomic mapping (EAM) was performed in 22 patients and showed
no scars in the atrium.  A total of 45 foci were identified (range 1-3 foci /
patient). Anatomically NAFAT foci were predominantly right atrial (n=35)
rather than left (n=10).  The NAFAT cycle length ranged from 270 to 490
(mean±SD; 380±69 ms) and was significantly lower in patients younger than
24 years of age. Ablation, attempted for 42 foci was successful in 33 (79%).
The success rate in the EAM group was 20/25 foci (80%) compared to 13/18
(72%) in the non-EAM group.  In conclusion, NAFAT is a rare arrhythmia
which predominantly affects women with no other associated cardiac disease.
It mainly occurs in the right atrium, affects all ages and is amenable to
catheter ablation.
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INTRODUCTION
The term atrial tachycardia continues to be used by many cardiac
electrophysiologists 1,2.  However, there is no clearly accepted definition of the
term.  Most use it to denote a focal atrial tachycardia (FAT), which, by definition
excludes macro-reentrant tachycardias such as atrial flutter.  Also, it is distinct
from atrioventricular reentrant tachycardia via a bypass tract and atrio-
ventricular nodal reentrant tachycardia.  The term usually excludes atrial
fibrillation although recent evidence suggests that atrial fibrillation may be a form
of focal atrial tachycardia in some patients 3.
Mechanistically, focal atrial tachycardia may be due to one of 3 etiologies:
reentry, automaticity and triggered automaticity.  To date the most
comprehensive review of this subject is a paper by Chen et al 4. They analyzed the
world medical literature on this subject between 1969 and 1997.  They
differentiated focal atrial tachycardias into those due to abnormal automaticity
and those not due to abnormal automaticity (so-called non-automatic FATs
(NAFAT)).  FAT due to abnormal automaticity was predominantly a disease of
the pediatric population.  Indeed, there are papers in the pediatric literature
which use the term ectopic atrial tachycardia to denote a FAT which is usually
incessant and due to abnormal automaticity 5.  Chen et al. were unable to
differentiate between reentry and triggered automaticity despite the use of
sophisticated electrophysiological and pharmacological maneuvers 4.  They
diagnosed NAFAT when the patient had a focal atrial tachycardia which was
inducible by pacing maneuvers in the electrophysiology lab.
There are few reports in the literature about NAFAT.  Apart from the two papers
from Chen et al. quoted above 1,4, we were able to find only two papers excluding
case reports in the Medline database 6,7.  Based on this, we decided to review our
clinical experience with this arrhythmia.  For the purpose of this paper we
utilized Chen et al. definition of NAFAT as a focal atrial tachycardia which could
be induced by pacing maneuvers in the electrophysiology lab with or without the
use of pharmacologic manipulation using isoproterenol or atropine 4.
PATIENTS AND METHODS
Between April 1994 and September 2000, 1328 catheter ablation procedures were
performed at our center. We did a database search on these patients. This
identified 96 patients with the terms atrial tachycardia, focal atrial tachycardia or
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ectopic atrial tachycardia.  We excluded all patients with AV nodal reentry
tachycardia (AVNRT), macro-reentrant tachycardia (i.e. flutters, incisional atrial
reentry tachycardia), sinus node reentry tachycardia, atrial fibrillation and
concealed accessory pathways. The electrophysiology reports of these 96 patients
were further scrutinized and any patient who did not fall into the definition of
NAFAT was excluded.  We finally found 38 patients who fit the description of
NAFAT. We reviewed the charts of all patients with respect to clinical
presentation, age at onset of symptoms, antiarrhythmic medication history and
history of hypertension, diabetes and other cardiac diseases. The
electrophysiology reports of these patients were reviewed in detail.
FIGURE 1. Induction of tachycardia.
Surface leads I, aVF, V1 and intracardiac recordings from the high-right atrium (HRA),
His bundle (HBE), coronary sinus (CS) and right ventricle (RV) are shown during
induction of tachycardia by pacing the HRA.
I
aVF
V1
HRA 3 3-4
HBEp3 1314
HBEm3 1112
HBEd3 9-10
CSp 4 9-10
CS 4 7-8
CSm 4 5-6
CS 4 3-4
CSd 4 1-2
RV 3 7-8
Non-Automatic Focal Atrial Tachycardia
49
Technique
Electrophysiological studies were performed in a standard fashion. Patients
received midazolam and fentanyl for sedation and analgesia.  Standard catheter
placement included a 6 French steerable decapolar catheter in the coronary sinus,
a quadripolar catheter in the right ventricle, a quadripolar catheter in the right
atrium, a hexapolar catheter in the His bundle area and in selected patients, a 20-
polar catheter in the tricuspid valve annulus.  Standard pacing and mapping
techniques were used to identify the mechanism of tachycardia and to localize the
foci (figs.1 and 2). Intravenous isoproterenol infusion (and atropine bolus) was
used as necessary. Ablation was performed using standard radiofrequency
techniques. Catheter manipulation was guided by fluoroscopy. In October 1997
FIGURE 2. AV dissociation during tachycardia.
Surface leads I, aVF, V1 and intracardiac recordings from the high-right atrium (HRA),
His bundle (HBE), coronary sinus (CS) and right ventricle (RV) show AV dissociation
during tachycardia, proving it to be atrial tachycardia (Same patient as Fig 1).
I
aVF
V1
HRA 3 3-4
HBEp3 1314
HBEm3 1112
HBEd3 9-10
CSp 4 9-10
CS 4 7-8
CSm 4 5-6
CS 4 3-4
CSd 4 1-2
RV 3 7-8
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electroanatomical mapping (Biosense, Diamond Bar, California) became available
at our center.  All analyses and maps were performed using bipolar electrograms.
The propagation maps generated by electroanatomical mapping (EAM) were also
examined to help differentiate macro-reentry tachycardia from focal atrial
tachycardia. Voltage maps were examined to look for scars (identified as areas of
low voltage (<0.1 mV)) in the atrium.
Treatment success
Successful catheter ablation was defined as non-inducibility of the clinical
tachycardia with pacing maneuvers performed under the same circumstances as
those of the baseline study.
RESULTS
The median age of the 38 patients at time of the procedure was 46 years, range
11-78.  There were 31 (82%) females. The mean age at time of presentation was
31 years (range 7-71 years). All but one patient presented with palpitations and 4
had syncope. The one asymptomatic patient was discovered to have an irregular
heart beat during a routine pre-military physical exam.
None of the patients had congenital heart disease or had undergone previous
cardiac surgery. Seven women (all older than 37 years) had documented
hypertension and another two had diabetes.
Antiarrhythmic medications were tried initially in 31 patients.  The number of
antiarrhythmic medications that had been tried ranged from 1 to 5.  The drugs
used included beta-blockers (n=19), digoxin (n=7), verapamil (n=6), flecaïnide
(n=5) and amiodarone (n=2).  Other class 1 agents were used in five patients.
Successful control was achieved with drugs in 2/6 patients who took verapamil, 2/
5 patients who were on flecaïnide and both patients on amiodarone. All the other
drugs were felt to be unsuccessful.
A total of 44 EP studies were performed in 38 patients, identifying 45 different
foci (range 1-3 foci per patient). The clinical tachycardia could be induced by
pacing maneuvers in all patients.  Sixteen patients needed isoproterenol infusion
to aid in the initiation of tachycardia and five others needed a combination of
isoproterenol and atropine.  In 17 patients the tachycardia could be induced
without isoproterenol or atropine.  Tachycardia foci were predominantly found in
the right atrium (n=35, 78%). (Fig. 3).
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Tachycardia cycle length at the EP study ranged from 270 to 490 msec (mean ±
SD, 380 ± 69). The cycle length in the patients younger than 24 years was found
to be significantly shorter compared to patients older than 37 years (342 ± 50 vs
390 ± 70) (p< 0.05).
Radiofrequencey catheter ablation (RFCA)
Catheter ablation was the first choice therapy in 7 patients.  Indications for
radiofrequency catheter ablation (RFCA) included progressive worsening of
symptoms, failure of medical therapy or association of medical therapy with
unacceptable side effects.
FIGURE 3. Distribution of the tachycardia foci in the atrium.
A flattened schematic drawing of the right and left atrium (RA and LA) with the
appendages turned upwards. Sites of successful ablation are shown by closed diamonds,
and open diamonds showing sites of failed ablation. The stars show tachycardia foci for
which ablation was not attempted. Note the clustering along the crista terminalis, the
right atrial free wall, os of the coronary sinus and Koch's triangle.
Chapter 5
52
Thirty-seven of the 38 patients underwent 42  RFCA procedures. In 1 patient, a
girl aged 17 years, RFCA was not done because the atrial tachycardia focus was
adjacent to the His bundle. There were two other foci (both in the high lateral
right atrium) for which catheter ablation was not attempted because the
tachycardia could not be sustained during the procedure and therefore could not
be mapped successfully (Fig 3).  Of the 42 ablation procedures, 23 (in 22 patients)
were guided by EAM and 19 (in 17 patients) were done without EAM. One
patient had an initial procedure without EAM, followed later by one with EAM.
Ablation of tachycardia foci was attempted for 42 atrial tachycardia foci in these
37 patients and was successful in eliminating 33 (79%) foci. Overall, after one or
more procedures, RFCA was unsuccessful in 6 patients, partially successful
(including successful ablation of at least one of multiple foci) in 3 patients and
complete success was achieved in 28 (76%) patients (16 with EAM and 12
without EAM). The success rate in the EAM guided group was 20/25 foci (80%)
versus 13/18 (72%) in the non-EAM-guided group (p=ns).
Patients in whom RFCA was unsuccessful did not differ from those where it was
successful when examined by sex, age, weight (of the patient) or location of the
foci.
Secondary tachyarrhythmia mechanisms were found in 9 patients. These
included AVNRT (6 patients), atrial flutter (2 patients) and one patient with
AVNRT and flutter. Slow pathway ablation for AVNRT was performed at the same
electrophysiological study in 5 patients and was successful in all. Sustained atrial
flutter was induced in 2 patients and was not ablated in either. In one other
patient AVNRT and sustained atrial flutter were induced. The former was ablated
in a separate procedure and no ablation was attempted for the latter.
Fluoroscopy time for the entire group was 21.5 ± 18.5 minutes (mean ± SD) and
procedure time was 3.6 ± 1.2 hours (mean ± SD).
The fluoroscopy time was 25 ± 19 minutes (mean ± SD) in the EAM group and
17 ± 16 in the non-EAM group. The procedure time was 3.7 ± 1.2 hours in the
EAM group (mean ± SD) versus 3.4 ± 1.1 in the non-EAM group.
The number of RF ablation lesions ranged from 1-33 (mean 8, median 5) for the
entire group.  The number of lesions in the EAM group was 1-33 (mean 9.4,
median 5) and 2-12 (mean 6, median 5) in the non-EAM group.
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Complications
No procedure related complications occurred in the EAM group. In the non-
EAM group, one patient developed a pericardial effusion with tamponade
requiring pericardiocentesis.
Follow up
After a mean follow up period of 29.3 months (range 5 to 81), two of the 28 (7%)
successfully ablated patients had recurrence of arrhythmia.  Both were
documented by event monitoring.  In one patient, the atrial tachycardia could not
be induced at electrophysiological study despite documentation by event
monitoring.  This patient was placed on metoprolol with successful symptom
control.  The other patient was referred to an outside center with special expertise
in ablation.  However, despite another initially successful ablation procedure, she
had further documented recurrence of arrhythmia.  She was placed on acebutolol
with successful symptom control.
Nine patients had either unsuccessful or partially successful ablation. Of these,
two patients had no further symptoms of tachycardia following successful
ablation of one of 2 foci. Five other patients were treated with antiarrhythmic
medication and 2 patients subsequently underwent complete atrioventricular
node ablation in combination with pacemaker therapy.
The patient in whom RFCA was not attempted due to proximity of the focus to
the His bundle was placed on a beta-blocker with successful suppression of the
arrhythmia.
DISCUSSION
NAFAT is a rare arrhythmia that predominantly affects women with no other
associated structural cardiac disease or scars in the atrium. It mainly occurs in the
right atrium, affects all ages and is amenable to catheter ablation.
Age
In a reanalysis of the literature on atrial tachycardia, Chen et al. reported that
non-automatic atrial tachycardia was predominantly a condition seen in older
people 4. This was in contrast to automatic focus atrial tachycardia, which was
predominantly seen in children 4. Rodriguez et al. studied the gender and age at
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presentation for a wide range of supraventricular tachycardias 8. In their report,
patients with focal atrial tachycardia ranged in age from 2-73 years (mean 35 ±
19). They, however, did not differentiate focal atrial tachycardias by mechanism.
Our patients, like theirs, came from a wide age range.  We also noted that the
younger patients in our group had a significantly shorter cycle length when
compared to the older patients.  The reason for this difference is unclear.
Gender
We found a female preponderance (82%) in our group of NAFAT patients. This
has been previously noted, but not emphasised, largely because other authors
have studied different arrhythmias. Markowitz et al. reporting on a series of
patients with focal atrial tachycardia, had a 71% female dominance in their group
of 17 patients 6. Likewise Rodriguez et al. had a female dominance (67%) in their
subset with paroxysmal atrial tachycardia 8. Both these groups did not specifically
look at NAFAT. It is interesting to note that in a re-analysis of atrial tachycardias,
Chen et al. did not note a gender difference even after differentiating automatic –
from non-automatic atrial tachycardia and paroxysmal from non-paroxysmal
atrial tachycardia 4.
Many common arrhythmia mechanisms show gender differences, but the cause of
such differences is unclear. For instance Wolff-Parkinson-White syndrome occurs
more often in males 9, while AVNRT is more common in women 10. Recently,
Larsen and Kadish reviewed the effect of gender on arrhythmias 11. They have
suggested a variety of influences, chiefly hormonal, which may affect cardiac ion
channel expression, autonomic tone, heart rate variability, baroreflex sensitivity
and dispersion of repolarization. However definitive proof regarding hormonal
influences on these electrophysiologically important factors is, as yet, lacking.
Right atrium versus left atrium
We found that NAFAT is predominantly a right atrial disease. This again fits in
with other previous studies. Chen et al. (in their re-analysis paper) found that
most non-automatic atrial tachycardias originate in the right atrium 4. They also
found that automatic focus atrial tachycardias are more commonly right atrial in
origin. Markowitz et al. also found most focal atrial tachycardias to be right atrial
6. Indeed 16 of their 17 patients with focal atrial tachycardias were right sided.
Marchlinski et al. reported the results of ablation aided by electroanatomical
mapping.  They reported 6 right atrial and three left atrial foci 7.
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Some authors have theorized that most right atrial tachycardias originate in the
crista terminalis. Indeed Lesh and Kalman preferred to clarify atrial tachycardias
by location rather than mechanism and created the concept of cristal tachycardias
12. The crista terminalis is noted to be an area of electrical inhomogeniety with
significant anisotropic conduction 13. Therefore, it is theorized that arrhythmias
can easily arise in this area.  Our series showed that roughly a third (13 of 36) of
the NAFAT’s in the right atrium originated in the crista terminalis. Other
important sites were the right atrial lateral free wall (n=10), the mouth of the
coronary sinus (n=6) and the region of the AV node (Koch’s triangle; n=4)
Structural heart disease
In our study, all patients had structurally normal hearts. No patient had
previously undergone cardiac surgery or had evidence of cardiomyopathy. Chen
et al. did not notice an association between structural heart disease and focal
atrial tachycardia 4. In the study by Markowitz et al., of the 17 patients with focal
atrial tachycardia, 7 had evidence of other cardiac disease ranging from mitral
valve disease to myocardial infarct 6. Also 2 patients had dilated cardiomyopathy.
Markowitz et al. did not classify their patients into automatic focus versus non-
automatic focus or into paroxysmal versus non-paroxysmal. Incessant atrial
tachycardia is a well-known cause of dilated cardiomyopathy. They reported that
1 patient had dilated cardiomyopathy secondary to atrial tachycardia, while the
other did not 6. None of the patients in our study population had dilated
cardiomyopathy, which is in line with the fact that none of our patients had
incessant atrial tachycardia.
Ablation
Catheter ablation has become the treatment of choice for patients with focal atrial
tachycardia. Our results show that successful ablation of NAFAT is possible, but
that the success rates are lower than generally seen for other types of
supraventricular tachycardias such as AV nodal tachycardia or accessory
pathways. We noted an improved success rate with the use of three-dimensional
EAM, although the value did not reach statistical significance (presumably due to
small numbers). Importantly EAM has not decreased the fluoroscopy time, which
was a highly anticipated benefit of this new technology. We feel that the reason for
the longer fluoroscopy time in the EAM group is because we were in the learning
curve for the use of this new technology in this period. Another potential factor
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may be selection bias with the patients having EAM coming from a more difficult
arrhythmia subset.   Marchlinski et al. 7 gave a detailed description of the method
of electroanatomical mapping.  They reported low fluoroscopy times although
they did not do a comparison between electroanatomical versus conventional
mapping.
Another possible cause for failure of ablation may have been the small size of
lesions with conventional RFCA.  Saline-cooled tip catheters have been shown to
increase lesion size and improve success rate of ablation in patients with complex
arrhythmia substrates 14.  We did not have this catheter technology available in
our institution.  One could speculate that this new technology could improve the
success rate for ablation in patients with this arrhythmia.
The recurrence rate for patients with successful ablation was high.  We did not
routinely perform repeat electrophysiological studies in the patients with
recurrence.  Hence we could not determine whether recurrence was due to
reactivation of the same focus or activation of a new focus.  One speculation is
that these patients have an intrinsically abnormal atrium with many potential foci
whose activity may vary from time to time.
Limitations
Our study was a retrospective review of cases seen over a 6.5 year period. We did
not use entrainment mapping techniques to differentiate between a reentry
versus triggered mechanism. Hence the exact nature of the arrhythmia is unclear.
However as pointed out by Chen et al., it is difficult (if not impossible) to
differentiate between triggered versus micro-reentry even with the use of time
consuming and sophisticated techniques 4. From a practical standpoint, the most
important aspect is the differentiation of automatic from non-automatic, since
many automatic tachycardias tend to be incessant and can lead to congestive
heart failure. We also did not perform drug studies on our patients. Engelstein et
al. suggested that adenosine would be expected to terminate atrial tachycardias
secondary to a triggered mechanism and proved their hypothesis in 1 patient 2.
Markowitz et al. showed that focal atrial tachycardia is transiently suppressed or
terminated by adenosine 6.
There has been a recent report from the Joint Expert Group from the Working
group of arrhythmia of the European society of Cardiology and the North
American Society of Pacing and Electrophysiology  15.  This group has proposed a
new classification of atrial arrhythmias.  They recommend the term focal atrial
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tachycardia (FAT) and include all mechanisms (automaticity, triggered and
microreentry) where the rhythm originates from a focus and spreads centrifugally
within this category.  They make no further attempt to subdivide this arrhythmia
based on potential mechanisms.  Based on their recommendations one would
surmise that we have reported a group of patients with focal atrial tachycardia
without further subdivision.
CONCLUSION
We have reported the largest single-center experience with a rare and poorly
understood form of supraventricular tachycardia. Further research is needed to
clarify some of the intriguing aspects of this arrhythmia including its predilection
for women without structural heart disease or scars in the atrium.
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ABSTRACT
Aims
In young patients, slow pathway ablation for treatment of atrioventricular
nodal reentrant tachycardia (AVNRT) carries a small but definite risk of
permanent AV block. The aim was to assess the efficacy of slow pathway
ablation aided by the Localisa mapping system.
Patients and Methods
RF modification of the slow AV nodal pathway was performed in 26 children
<19 years of age (median age 9.8 years, range 3 to 18.9). Three measures to
limit the risk of AV block were applied: 1) Use of LocaLisa, a non-fluoroscopic
mapping system, to determine and mark the location of the AV node/ His
bundle axis, and monitor ablation catheter position, 2) continuous atrial
stimulation during RF delivery to monitor AV conduction, 3) gradual increase
of RF power during RF ablation.
Results
AVNRT was rendered non-inducible in all patients. Dual AV physiology was
abolished in 24/26 patients; two patients had single atrial echoes at the end of
the procedure. At follow-up, AVNRT recurred in 3 patients (including the
above 2), necessitating a second procedure. The median number of RF
applications was 4 (3-8); median fluoroscopy time was 16 (7-33) minutes. One
patient developed transient second degree AV block, with full recovery within 6
weeks of the procedure.
Conclusion
RF modification of the slow AV nodal pathway in children can be safely
accomplished, achieveing the ideal end-point of abolishing dual AV physiology,
aided by use of the Localisa mapping system.
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INTRODUCTION
Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common form
of supraventricular tachyarrhythmia in young adults 1. It accounts for between
11-13% of SVT in infants and 13-23% in the whole pediatric population 2,3. In
AVNRT, there are multiple AV nodal pathways, which are functionally and
anatomically distinct, forming the electrophysiologic basis for reentry within the
AV node. During the last decade radiofrequency (RF) catheter ablation
modification of the slow pathway has become the method of choice for curative
therapy of AVNRT in symptomatic patients. Most studies have been performed in
adult populations demonstrating success rates in excess of 95% 4. Of concern in
the paediatric population is the risk of inadvertent AV block during AV node
modification, with the potential requirement for lifelong pacemaker therapy 5,6.
In this study we present the experience with catheter ablation of AVNRT in
children using LocaLisa mapping system 7-9.
PATIENTS AND METHODS
Patients
Twenty six consecutive patients aged <19 years (17 female, 9 male) with AVNRT
underwent RF slow pathway modification at our institution (29 procedures).
Their median age was 9.8 years (range 3 to 18.9), and median weight 42 kg (15.0
to 59). All children had a structurally normal heart confirmed on
echocardiography. Surface 12 lead electrocardiograms at rest were normal in all.
The median duration of symptoms prior to ablation was 14 (11-54) months, and
all patients had undergone trial of antiarrhythmic drug therapy (median of 2
drugs/day). Indication for ablation was based on patient or parent preference in
all cases. All medical and electrophysiologic (EP) records were reviewed for
procedural details, complications, and follow-up.
Electrophysiologic Studies
All but 2 of the procedures were performed under general anesthesia, after
written consent was obtained. Antiarrhythmic therapy was discontinued for at
least 5 half lives prior to ablation. Electrode catheters were introduced via the
femoral vein, and positioned in a standard manner in the right atrium, ventricle,
and coronary sinus. The His bundle location was entirely mapped out using a
standard temperature controlled mapping/ ablation catheter, and displayed on
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the Localisa monitor (figure). The right ventricular catheter was used as the
reference catheter for the Localisa mapping system. Using a standard
extrastimulus protocol, dual AV physiology (defined as a ≥ 50 ms increase in the
A2-H2 interval with a 10-ms decrement in the A1-A2 interval or ≥ 50 ms increase
in the A-H interval with a 10-ms decrease in the atrial paced cycle length) was
demonstrated in all patients, and sustained AVNRT (defined by the criteria of
Ross et al) 10 was induced either at baseline state (17 patients, 19 procedures) or
with the use of isoproterenol by infusion (0.02 mcg/kg/min; 9 patients, 10
procedures). The slow pathway was targeted for ablation in all patients.
LocaLisa mapping system
This system, which is commercially available (Medtronic, USA) allows continuous
monitoring of intracardiac electrodes. Previous clinical studies have confirmed
the efficacy and accuracy of this mapping system 7-9. All studies described here
were performed using the Localisa system.
FIGURE.Localisa map in a right anterior oblique projection, demonstrating the location
of the compact AV node and proximal His bundle (blue dots represent sites at which
His bundle electrograms were recordable). Individual RF lesions are depicted in red,
and the ablation catheter is also shown (with tip electrode depicted in red). The
location of the coronary sinus is also shown (yellow/green dots).
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Ablation
Ablation was commenced approximately 12mm (range 11 to 15) below (inferior
to) the location of the proximal His bundle, on the atrial aspect of the tricuspid
valve annulus, the latter landmark being based on the appearance of an atrial
potential on the distal electrogram of the ablation catheter. This approach was
identical to that used in adult patients also during the same time-frame. The
localization of the His bundle is based on the steepest bipolar His potential while
moving the catheter supero-inferiorly around the His bundle area. By doing so at
progressively more posterior sites, one can follow and mark on the Localisa screen
the His bundle from its distal to its most proximal extent (antero-posterior
extent) (figure). The filter settings for the intracardiac electrograms (Prucka), to
eliminate far-field signals were 50-500 Hz bandpass filtering for bipolar
electrograms and 0.05-500 Hz for unipolar electrograms. The Localisa system
used a 1.5 to 2 second averaging to correct for respiratory variations. Slow
pathway potentials were not routinely searched for, but when they were observed
(n=7 patients), they were seen as a “slow” hump, usually positive on the bipolar
electrogram. Analysis of the location of the slow pathway potential in these 7
patients confirmed that they could be identified between 5-10 mm inferior to the
His bundle and 0-5 mm posterior to the tricuspid valve annulus. Sites at which
these potentials were seen were definitely targeted for ablation. The compact node
could not be identified on the basis of the electrograms, but we take the proximal
extent of the His bundle, as marked on the Localisa screen, to be the superior/
anterior margin of the AV node. RF application was performed during
continuous atrial pacing, to ensure the presence of AV conduction during each
RF application. Pacing was commenced at a cycle length slightly above the resting
sinus cycle length (usually at cycle lengths of between 500 to 600 ms).The
measured sinus cycle lengths prior to commencing atrial pacing were between
513 and 832 ms. Junctional ectopy during RF delivery, which was used as a
marker of proximity to the optimal target area, could be reliably identified. With
the occurrence of junctional ectopy the atrial pacing rate was increased to re-
enable monitoring of anterograde conduction. Sustained junctional tachycardia
during RF application was seen in only 5 patients, at cycle lengths of between 445
– 526 ms, and in all cases pacing at rates higher than the junctional rhythm was
possible. Continuous atrial pacing, or changes in pacing rate during RF
application did not result in catheter tip instability, or influence the need to
terminate lesion application in any patient.
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Retrograde conduction of the junctional ectopic beats to monitor retrograde fast
pathway conduction was not routinely performed. At sites where junctional
ectopy was observed during RF application, the application was continued for
upto 60 seconds. The power output of the RF generator was slowly increased,
starting at 5W, and increasing gradually to achieve tip electrode temperature in
excess of 500C. When high grade junctional ectopy, or sustained junctional
tachycardia (cycle length >600 ms) was observed at moderate RF power levels (10
to 20 Watts) this was taken as indicating extreme proximity to the AV node, and
ablation at these sites was discontinued, and recommenced at a greater distance
from the AV node.
After each RF application during which accelerated junctional rhythm was
present, the atrial pacing protocol was repeated to either demonstrate dual AV
physiology, or reinduction of tachyarrhythmia. If either of these was present,
lesions were progressively made closer to the His bundle recording sites, as shown
on Localisa (figure). The new site was chosen at between 1 to 4 mm from the
previous RF application site, as measured from the Localisa system. The end-
point of the procedure was absence of dual AV physiology in 24 of 26 patients. In
two patients, both early in our experience (patients 7 and 8 respectively in Table 1)
dual AV physiology and single atrial echoes were present at termination of the
procedure, but AVNRT was non-inducible. This was accepted as the end-point in
these two patients.
RESULTS
RF Catheter Ablation
Catheter modification of the slow pathway resulting in non-inducibility of
AVNRT was accomplished in all 26 patients. During each RF application, the
distance from the ablation site to the most proximal His bundle electrogram
recording was recorded. The median distance of the last RF application site to the
His bundle was between 7 (5 to 11 ) mm. In this patient cohort with a large age
range, no differences were observed with regard to the age of the patient and the
distance of the successful ablation location from the proximal His bundle
electrogram. Two patients had evidence of persisting dual AV physiology and
single atrial echo beats. As mentioned previously, early in our experience with
children, this was chosen to be the end-point for the procedure in these two cases.
None of the other patients had evidence of dual AV physiology at termination of
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the procedure. The median number of RF applications was 4 (3 to 8); the median
fluoroscopy time was 16 (7 to 33) minutes. The A-H interval remained virtually
unchanged (72 ± 12 msec pre-ablation versus 79 ± 21 msec post-ablation). There
were one episode of second degree AV block in a 5 year old girl, with fixed 2:1 AV
conduction (confirmed at various atrial pacing rates) following slow pathway
ablation, and absence of retrograde VA conduction. A total of 4 RF pulses had
Table 1.
Patient demographics and follow-up
No Age (years) Weight (kg) RF pulses (No) Fluoroscopy (min) Follow-up (months)
1 16.5 47 8 17 61
2 14 49 5 9 60
3 17.1 47 5 19 56
4 12.3 42 4 12 54
5 16.9 59 4 7 53
6 14.5 48 4 16 51
7 3.1* 15 4.....(4) 14.....(17) 43
8 6.6* 20 4.....(3) 12.....(19) 42
9 14.3 50 7 21 37
10 18.9 56 6 19 33
11 18.7 51 4 16 30
12 4.8 21 6 14 28
13 3 15 3 11 28
14 6 27 4 18 26
15 6.1 26 6 33 26
16 14.7 52 8 29 24
17 14.1 49 4 14 24
18 11 45 7 16 21
19 9 42 5 17 21
20 11.6 36 3 13 19
21 9.9 30 4 21 14
22 10.8* 45 4.....(4) 12.....(20) 14
23 7.2 24 7 19 9
24 4.1 19 3 10 4
25 6.7 27 7 18 3
26 5.3# 22 4 15 3
Symbols: * refers to the 3 patients with documented recurrence of AVNRT, who underwent a second ablation
procedure. The fluoroscopy times and number of lesions for re-do procedures are given in parentheses. # refers
to the single patient who had transient second degree AV block.
Follow-up refers to the interval at most recent evaluation, after the last ablation procedure.
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been delivered in this patient, at a median distance of 7 (5 to 8) mm from the His
bundle. During the last RF application, there had been no evidence for catheter
instability. No isoproterenol or atropine was administered to assess AV
conduction, and no corticosteroids were administered. The patient was as usual
24 hours post-procedure, on oral aspirin therapy. Overnight telemetry had
confirmed ventricular rates of >60/min throughout. At outpatient follow-up 5
weeks later, normal 1:1 AV conduction was documented. Three months post-
ablation, transesophageal atrial pacing performed in this patient confirmed a
Wenkebach cycle length of 340 ms, which was considered to indicate restoration
of functional integrity of the AV node. Apart from this patient, no episodes of AV
block occurred during any of the RF applications, and none of the other patients
had any procedure-related complications. Patients were discharged on the
following day, on oral aspirin therapy (5mg/kg/day) for 6 weeks.
Recurrence Rate
In three patients, AVNRT recurred within 3 months of the initial ablation
procedure (Table). This included both patients with evidence of persisting dual
AV physiology. The third patient did not demonstrate dual AV physiology at the
end of the initial ablation procedure, but had documented AVNRT during a
second EP study. All 3 patients underwent a second ablation procedure at 3, 3 and
6 months after the initial procedure. In both patients with dual AV physiology
demonstrated at restudy, this was abolished. The third patient showed progressive
A-H prolongation during atrial extrastimulus pacing, with induction of AVNRT,
but without a classical A-H jump. The slow pathway was again modified, using
the techniques described previously. None of these 3 patients has had recurrence
of tachyarrhythmia at follow-up of >12 months.
Follow-up
The median follow-up duration was 25 (3 to 61) months after the last ablation
procedure. Serial Holter recordings at 6 months (N=19) and at 12 months
(N=11) post-ablation did not demonstrate any AV conduction disturbances.
DISCUSSION
Catheter ablation by RF current application is currently the accepted treatment
modality for AVNRT in adults. The frequency of this arrhythmia appears to be
age-dependent, although it is increasingly diagnosed in childhood 11. Of
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particular concern is the risk of inadvertent AV block during slow pathway
modification. In a review of 314 children and adolescents with AVNRT, 5 (1.6%)
developed advanced second- or third-degree AV block as a complication of the
procedure 5. This rate did not differ from the 1% risk of AV block reported in
adult series of patients with AVNRT. More recent follow-up studies in children
reveal a complication rate for AVNRT ablation that appears to be age dependent,
varying from 18% in patients <5 years of age to 3% in patients aged between 5
and 21 years 6. Fluroscopy times and radiation exposure is another important
issue when dealing with children. The fluoroscopy times in our series (median 16
minutes, range 7 to 33 min) compare favourably with that reported in the
Pediatric Radiofrequency Ablation Registry (29.3 ± 25.7 minutes) 6.
The potential risk of RF lesion growth resulting in late onset AV block should also
be considered, during ablation procedures close to the AV node in young patients 12.
In this report we present 26 children with symptomatic AVNRT who underwent
RF catheter modification of the slow AV nodal pathway as a curative therapy. The
results are comparable to that in adults. Moreover, none of the treated children
developed permanent AV conduction disturbances at follow-up.
There are no clear recommendations concerning the end-point AVNRT ablation.
The end-point of non-inducibility of AVNRT even in the presence of dual AV
physiology and single atrial echo beats is generally accepted, and has been shown
to be associated with long-term success in adults. Unlike most previous reports of
AV node modification, we attempted to abolish dual AV physiology during the
ablation procedure in the majority of patients. This aggressive approach was
aided by the use of the Localisa mapping system which enabled the location of
the ablation catheter electrodes to be precisely monitored, and the distance from
the His bundle to be measured. Ancillary precautions that were taken during RF
energy application included incremental AV pacing, and energy delivery starting
at low power output, with progressive increase in output to achieve the desired
catheter tip temperature. Both patients in whom the desired end-point was not
achieved, and where non-inducibility of AVNRT was used as a measure of
success, had recurrence of the original tachyarrhythmia within 3 months of the
ablation procedure, necessitating a second procedure. The only other patient with
a documented recurrence did not have classical dual AV physiology during the
second EP procedure, as described above, although the arrhythmia had all the
characteristics of AVNRT.
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One of the potential limitations of this study is that patients were not randomised
to ablation with and without the use of Localisa, so that direct comparisons
between the two subgroups from the same institution cannot be made.
Recurrence rates following initial ablation (3/26 patients, or 12%) were rather
high, although in 2 of the 3 patients non-inducibility of AVNRT with persistent
dual AV physiology was the end-point used. The ideal end-point of abolition of
dual AV physiology was eventually successfully accomplished in all patients,
unlike all previous reports of AVNRT ablation 13. This end-point was achieved
with fluoroscopy times comparable to, or less than that reported for other series
4,5,6,13. With a relatively small cohort of patients and a modest follow-up interval, it
is not possible to make recommendations concerning the ideal end-point for
AVNRT ablation in children.
In conclusion, continuous electrode localization, in combination with the ability
to measure the distance to the AV node/His bundle axis, improves the safety and
efficacy of catheter modification of the AV node in young patients with AVNRT.
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ABSTRACT
Background
Background: Epicardial pacemaker implantation is the most common
approach for small children requiring pacemaker implantation though is
not free from complications. This report reviews the experience with
endocardial pacemaker implantation in children ≤ 10 kg at two centres as an
alternative approach.
Methods and Results
39 children, median age 3.8 months (2 days-35 months), weight 4.6 (2.3-10)
kg underwent endocardial permanent pacing (VVI/R in 38, DDDR in 1).
Indications for pacing were complete heart block (CHB) in 34 (congenital
in 21, post-surgical in 12, congenitally corrected transposition of the great
arteries 1), long QT syndrome in 3 and sinus bradycardia in 2. Two children
with post-surgical CHB died 7 days and 3 weeks post-implantation
respectively, due to heart failure and septicemia, despite appropriate
pacemaker therapy. Over a median follow-up of 4.3 years (9 months-15.3
years) 12 patients underwent 18 generator replacements. Five patients were
upgraded to physiological pacing. Ten patients underwent 12 ventricular
lead advancements. Ventricular lead extraction was attempted 11 times in 9
patients and succeeded 10 times. Two patients were converted to epicardial
dual chamber systems. Two pre-pectorally placed generators required
resiting due to threatened skin necrosis. Infective endocarditis on the lead, 9
months post-implant required removal of the system in one patient. The
subclavian vein was found to be asymptomatically thrombosed in 4.
Conclusion
Endocardial permanent pacing is feasible and effective in children ≤ 10 kg
and an acceptable alternative to epicardial pacing.
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INTRODUCTION
Many pediatric centers continue to advocate the epicardial approach to
permanent pacing in children younger than five years of age or less than 30 kg
in weight 1. The major reason for avoiding the endocardial approach is the
perceived risk of venous occlusion, growth related lead problems and the need
for future lead extractions and replacements 2. Skin erosion at the generator
site has also been of concern with pectoral placement of the generator.
Reduction in lead body and generator size and the use of intravascular loops
to cater for future growth has lessened many of these concerns 3-5. Most of the
reports of endocardial pacing in very young children 3-10 have small numbers
or have grouped them with older patients so that the total published
experience is small and follow up duration is short. The largest report to date
has been of 24 patients ≤ 15kg at the time of implantation 4. An increasing
number of centres now prefer endocardial pacing in children older than 1 year
and/or weighing more than 8 kg 11. As problems are to be expected in the
smallest children, we present our experience in a large series of children ≤ 10.0
kg at the time of pacemaker implantation.
PATIENTS
Between October 1987 and August 2002, thirty-nine children (20 female, 19
male; 32 at Guy’s Hospital, 7 at Wilhelmina Children’s Hospital) ≤ 10 kg in
weight received an endocardial pacing system. Their weights ranged from 2.3
to 10 kg (median weight 4.6 kg) and their ages from 2 days to 35 months
(median age 3.8 months). Indications for permanent pacing are given in Table 1.
Congenital complete heart block (CHB) was present in 21 patients (isolated in
19). Five patients underwent pacing within the first 48 hours of life due to
heart failure and very low heart rates. In the other 16, a pacemaker was
implanted between two weeks and 13 months of age, based on one or more of
the following; heart failure, failure to thrive, syncope, increase in heart size,
daytime heart rates below 50 beats per minute, runs of more than three
ventricular extrasystoles, and QT interval prolongation. In 14 children isolated
congenital CHB was associated with maternal anti-Ro antibodies, in 2 the
anti-Ro antibody status was unknown and in 3 was negative. One of the
mothers, negative for anti-Ro antibodies, had varicella during pregnancy.
Eleven children required permanent pacing for (CHB) shortly after surgical
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Table 1.
Indications for pacing
Arrhythmia No. of patients Additional structural heart disease
Congenital CHB 21
- Isolated 19 Patent arterial duct (4), Atrial septal defect (1)
- Congenital heart disease 2 Tetralogy of Fallot (1), cTGA (1)
Postoperative CHB 11 Coarctation of aorta (3), TGA (2) , Tetralogy of Fallot (1),
- VSD closure 7 Total anomalous pulmonary venous drainage (1),
- AVSD closure 3 Left atrial isomerism (1), Patent arterial duct (1),
- VSD enlargement 1 Atrial septal defect (1), Dysplastic atrioventricular valve (1)
Late Postoperative CHB 1 TGA & VSD
cTGA – postnatal CHB 1 Atrial septal defect, Ventricular septal defect,
Patent arterial duct & Ebstein’s anomaly
Long QT syndrome 3
Sinus node disease 2 Atrial septal defect (1)
CHB = complete heart block; cTGA = congenitally corrected transposition of the great arteries;
TGA =transposition of the great arteries; VSD = ventricular septal defect; AVSD = atrioventricular septal defect.
repair of a congenital heart defect. They had undergone closure of a
ventricular septal defect (VSD) in 7, atrioventricular septal defect in 3 or
enlargement of a VSD in 1 at the time of an arterial switch for transposition
of the great arteries. A 17-month-old female was paced for late postoperative
CHB, after a neonatal arterial switch operation and VSD closure. A 3-month-
old child was paced for postnatal onset complete heart block with congenitally
corrected transposition. Three patients had a pacemaker implanted as
combination therapy with â-blockers for long QT syndrome. Two patients
were paced for sinus bradycardias and reflex anoxic seizures.
In two of these children there was a right to left shunt at the time of
pacemaker implantation. The first had congenital CHB and Tetralogy of Fallot
and had surgical repair 6 months after pacemaker implantation. The second
with congenitally corrected transposition, an atrial septal defect, VSD and
patent arterial duct had duct ligation after pacemaker implantation which
exposed the right to left shunting at atrial level. The VSD is small and he is
awaiting transcatheter occlusion of the atrial septal defect when he is older.
All but one of these children received a single chamber endocardial
pacemaker. During this period 5 other children ≤ 10.0 kg underwent epicardial
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pacing. A child at Guy’s Hospital with congenital CHB weighing 1.5 kg had a
single chamber pacemaker. At Wilhelmina Children’s Hospital, 4 children had
dual chamber pacemakers implanted at the time of corrective cardiac surgery
as they were considered to need the haemodynamic benefit of atrioventricular
synchrony.
TECHNIQUE
Under general anesthesia, venous access was gained by percutaneous puncture
of the left (the majority) or right subclavian vein. Via a 4-7 French introducer,
a unipolar (n=13) or bipolar lead (n=27) was introduced and positioned in the
right ventricular apex or outflow tract. Leads were steroid-eluting in 25 and
were active fixation in 19. In the only patient to receive a dual chamber
system, for severe postoperative heart failure, an atrial lead was introduced via
an axillary vein cutdown on the same side as the subclavian vein puncture. All
the leads were placed with a redundant loop in the atrium, to allow for
somatic growth. The generator was placed in a sub-pectoral (n=7) or a pre-
pectoral (n=23) pocket or in a pocket in the anterior abdominal wall (n=9),
depending on the size of the generator in relation to the patient’s size.
Abdominal implants were predominantly in the early patients in this study, in
those < 2.5 kg and in the infant with a dual chamber pacemaker. In these
patients, the extravascular part of the lead was tunnelled subcutaneously to the
pacemaker pocket. The lead was secured subcutaneously at its entry point into
the subclavian vein, using non-absorbable suture material, usually without the
protective sleeve to reduce bulk. During the implantation procedure all
patients received antibiotic prophylaxis intravenously, continued intravenously
for 48 hours and orally for five days. A variety of different leads (Table 2) and
generators (Table 3) were used, reflecting the technological advances over this
15-year period.
RESULTS
At implantation good pacing and sensing thresholds were achieved in all cases.
Two children with post-surgical CHB died 7 days and 3 weeks after pacemaker
implantation.  The former had left atrial isomerism and had undergone repair
of an atrioventricular septal defect at 6 weeks of age. The temporary epicardial
pacing wires placed at surgery became infected and failed, with a suppurative
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Table 2.
Pacemaker leads used at initial implantation
Lead model n Years of implant Size (French) Fixation Polarity Steroid eluting
Ventricular
- Biotronic PE60/4DNP 3 ’87 – ‘88 5 P U -
- Siemens 424M/60 3 ’87 – ‘88 4.8 P U -
- Biotronic TIR-60-BP 1 ‘92 6.6 P B -
- Medtronic 4024 2 ‘92 5.8 P B +
- Siemens EL 1050T 1 ‘92 6 P B -
- Vitatron Slimtine 3 ’92 – ‘01 5 P U -
- Vitatron IMD 49B 6546 7 ’96 – ‘98 5.7 P B +
- Biotronic Y60-BP 2 ‘97 6.6 A B -
- Medtronic 4023 1 ‘97 3.6 P U +
- Medtronic 5067 1 ‘99 6.6 A U +
- Sulzer/Osypka K467-40 1 ‘99 4 A U -
- Medtronic 5076 6 ’99 – ‘01 6.2 A B +
- St. Jude Tendril SDX 1488 8 ’00 – ‘01 6.1 A B +
Atrial
- Sulzer/Osypka K467-40 1 ‘99 4 A U -
P = passive; A = active; U = unipolar; B = bipolar.
pericarditis precluding implantation of an epicardial pacing system. A dual
chamber endocardial system was implanted as she was in severe heart failure.
Despite effective sequential pacing, she died seven days later from sepsis. The
second patient had undergone a hemodynamically suboptimal repair of total
anomalous pulmonary venous drainage, VSD and aortic coarctation. Effective
endocardial ventricular pacing allowed, the child to go home for palliative care
and she succumbed from congestive heart failure and secondary fungal sepsis
3 weeks after pacemaker implantation.
Follow-up
Follow up data were obtained for 36 patients over a median follow up time of
4.3 years after first implantation (range 9 months to 15.3 years).  One patient
was lost to follow-up after emigrating. During this period 16 (44%) patients
continued with their current generator in situ (range 9 to 63 months; mean 28
months), 10 (28%) had the system revised at the end of life of the generator
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(range 48 to 74 months; mean 61 months) and 10 (28%) required an
intervention prior to the end of life of the generator  (range 2 days to 31
months). Fig. 1 gives an overview of follow up to the major end points and
Figs. 2 and 3 give a detailed outcome including subsequent interventions. A
total of 30 re-interventions occurred during this follow up period (11 patients
having one, 6 patients having two, 1 patient having 3 and 1 patient having 4
re-interventions). Of the 36 patients, 31 (86%) continue with an endocardial
pacing system, 2 have an epicardial system and 3 are no longer paced.
Early Re-intervention
In one child the lead was found by echocardiography to have crossed a patent
foramen ovale and was successfully repositioned two days after implantation.
Three patients, receiving a pre-pectoral pacemaker system at two, three and
eight days of age (weights of 3.1 – 3.3 kg), had wound closure or generator
pocket problems despite use of some of the smallest generators (Finesse (n=1),
Microny (n=2)  – Table 3). Two of them underwent repositioning of the
generator because of threatening skin necrosis; one (three days old at
implantation) from a pre- to a sub-pectoral pocket and the other (eight days
old at implantation) from a pre-pectoral to an abdominal pocket, respectively
two days and three months post implantation. In the latter patient there was
threatened erosion again at 2 years of age and the system was removed and
not replaced due to an occluded subclavian vein. At this stage her varicella
myocarditis had resolved and she had a good ventricular escape rate despite
continued heart block – she remains unpaced 7 years later. The third patient
had been given steroids in utero for four months prior to delivery in an
attempt to arrest or reverse the progression of AV-block. Following
pacemaker implantation the wound would not heal properly and was
resutured 2 months after implantation. At 20 months there was a pocket
infection and the system was removed and replaced with an epicardial DDD
pacemaker. The subclavian vein was noted to be occluded during the lead
extraction. One patient with surgically acquired CHB after VSD repair  with a
residual leak developed infective endocarditis on the tricuspid valve and
pacing lead 9 months after pacemaker implantation. The pacing system was
removed but not replaced as the patient had recovered sinus rhythm (and
remains in sinus rhythm 9 years later). A patient with surgically acquired CHB
after an arterial switch operation with VSD enlargement, developed
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progressive mitral and aortic regurgitation and severe heart failure. Four
months after implantation of the endocardial pacemaker, she had a mitral
valve replacement and aortic valve repair at which time the endocardial pacing
system was removed and an epicardial DDD pacemaker was implanted to try
improve myocardial performance. In 4 patients (3 with an abdominally sited
generator) the redundant atrial loop was inadequate and the lead had to be
advanced prior to generator end of life at 3, 10, 13, 31 months after implant.
In one of these lead advancement failed and the lead was replaced.
Generator replacement and system removal
Generators were electively replaced 17 times in 12 patients at end of life of the
generator. One other patient underwent generator replacement at the time of a
necessary lead advancement for lead stretch.
In two patients the endocardial pacing system was replaced by an epicardial
DDD system (described in early re-intervention section, Fig. 2). In three
patients the entire pacemaker system was removed and not replaced. Two have
Table 3.
Generators at initial implantation
Generator n Years of implant Weights / volumes
Medtronic Spectrax SX 5985 1 ‘87 45 gr / 20 cm3
Biotronic Mikros 02 2 ’87 – ‘88 26 gr / 10 cm3
Pacesetter Pheonix 251-6 3 ’87 – ‘88 33 gr / 12 cm3
Biotronic Pikos 01 1 ‘92 27 gr / 8.9 cm3
Biotronic Nanos 01-BP 1 ‘92 23 gr / 10.8 cm3
Vitatron Ultrafinesse 204 1 ‘92 18 gr / 7 cm3
Vitatron Ultrafinesse 203 1 ‘92 18 gr / 7 cm3
Siemens Sensolog III 2034 II 1 ‘92 26 gr / 14 cm3
Vitatron Finesse 201 1 ‘95 21 gr / 8.5 cm3
St Jude Microny II SR+ 2425T 9 ’96 – ‘01 12.8 gr / 5.9 cm3
Medtronic Thera SR 8960 I 2 ’97 – ‘99 21.5 gr / 9.7 cm3
St Jude Regency SR+ 2400L 4 ’98 – ‘01 18.5 gr / 8.6 cm3
Vitatron Diamond II * 1 ‘99 25 gr / 11 cm3
St Jude Microny kSR 2535K 2 ’99 – ‘01 12.8 gr / 5.9 cm3
St Jude Microny II SR+ 2525T 9 ’00 – ‘01 12.8 gr / 5.9 cm3
* Dual chamber pacemaker
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been described in the early re-intervention section (Fig. 2). A third child had
received a pacing system at 13 months of age, because of reflex anoxic
seizures. Fourteen years later she was found to have normal sinus node
function. Her pacing system was completely removed using a diathermy
sheath to facilitate lead extraction.
Five patients were upgraded to physiological pacing (* in Figs. 2 and 3) at the
time of an elective generator replacement (ipsilateral to the original implant).
In an eight-year old, paced for long-QT syndrome, this procedure failed,
because of intractable atrial fibrillation and the atrial lead was removed. He
was subsequently upgraded to a dual chamber defibrillator at the age of 13
years. In the other four patients, the upgrade procedure was uncomplicated
(2 = DDD, 2 = VDD) 4, 4, 6, and 11 years after initial single chamber
pacemaker implantation.
Lead advancement and replacement
Lead advancement
Ventricular lead advancement was attempted 12 times in 10 patients and failed
once (Fig. 4). In one child a bipolar lead was damaged during the
advancement procedure and was converted to a unipolar lead. In 4 patients,
lead advancement was a primary procedure (described in early re-intervention
section, Fig.2) but in the remainder lead advancement or replacement was as
part of a generator change/upgrade procedure.
Lead extraction
Ventricular lead extraction was performed 11 times in 9 patients (with
additional atrial lead extraction in 2 of these, resulting in a total of 13 lead
extractions). Indications for extraction were: high threshold and/or low
impedance (4), lead damage during generator replacement or lead
advancement procedure (2), stretched leads (2), Siemens 1050T advisory (1),
Accufix atrial lead advisory (1), unipolar lead replaced with bipolar for
submuscular generator (1), infection (1), sinus rhythm recovery (1).
The technique used for the extraction varied with the time period and weight
of the child. In the early years, leads were extracted by mechanical traction on
the lead. In later years however, subclavian extraction sheaths (countertraction
and radiofrequency sheaths) were used in older children. In a 15.9 kg child in
whom the subclavian vein was occluded, a modified extraction technique was
used. The lead was snared from the femoral vein and drawn into a femoral
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FIGURE 4. Chest radiograph of 3 week-old, 3.7 kg neonate with congenital CHB at
prepectoral implant (4a) and 4 yrs 9 months later (weight 20 kg) at end of life of
Microny generator (4b). Lead advanced to increase size of loop with Regency pacemaker
placed subpectorally (4c).
sheath. Prior to this, an exchange length coronary guidewire was advanced
into the stylet channel of the lead, exiting the pectoral implant site. In this way,
a subclavian to femoral venous guide wire circuit was created when the lead
was pulled out the femoral site. Over this guidewire circuit, a sheath was
placed from the subclavian site, creating access to place a new ipsilateral lead.
Only one lead could not be removed during an upgrade procedure in a seven
year old. The ventricular lead was abandoned when the redundant atrial loop
was found to be adherent to the atrial myocardium. A new ventricular lead
was inserted through the ipsilateral cephalic vein and an atrial lead was
inserted through the ipsilateral subclavian vein. At 14 years, this same patient
had the ventricular lead advanced and uncomplicated ipsilateral atrial lead
extraction and replacement (Accufix advisory).
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Ipsilateral lead or leads were placed via the same subclavian vein during 7 of
these procedures. In 3 patients (described in system removal section) the
system was not replaced. One patient with a thrombosed subclavian vein
received a contralateral lead and generator implant when access could not be
maintained.
Subclavian vein occlusion
Four patients (11%) were noticed to have asymptomatic subclavian vein
occlusion during a lead extraction procedure as detailed in the preceding
sections and Figs. 2 and 3. Implants had been performed at weights of 2.7, 3.1,
3.2 and 4.6 kg with various leads (Vitatron Slimtine, Medtronic 4024, Vitatron
IMD 49B 6546, Biotronik Y60-BP – Table 2).
DISCUSSION
The early years of paediatric pacemaker implantation were complicated by the
large size of the generators, the short longevity of the generators, lack of
fixation methods for endocardial leads and stress on the leads during growth
of very small children 12. Re-operation rates for both endocardial and
epicardial pacing in the 1970s were high with a majority of children having a
re-operation within 2 years of the initial implant due to early generator battery
depletion, lead complications and wound problems. With improvements in
epicardial leads and generators sizes, there was a swing towards epicardial
pacing, but pocket erosion, infection and electrode problems remained a
major cause of morbidity 13-15. Electrode failure due to acute exit block,
thresholds rises and lead fractures were estimated to be as high as 30-40%
over 5 years during the 1980s 15-17. Higher chronic stimulation thresholds
resulted in premature battery depletion and consequently the need for
repeated operations. The use of steroid eluting epicardial leads in the 1990s
contributed to a lowering of the acute and chronic stimulation thresholds
compared to epicardial pacing with non steroid-eluting leads 7, 18, 19. Acute exit
block and lead fractures still occurred 20-22. Beder et al’s series of steroid-
eluting epicardial leads in 12 patients with a median age of 6 yrs (oldest 49
years) had 3 acute exit blocks and 1 fracture 20. Cohen et al’s large series of 123
“children” < 22 years of age, the majority with congenital heart disease,
undergoing epicardial pacing (40% steroid-eluting) reported a 26% lead failure
rate by 5 years with a mean time to failure of 2.5 +/- 2.4 years 22.
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The progress in epicardial pacing was accompanied by improvements in
equipment and implantation techniques for endocardial pacing. The reduction
in generator size, the development of endocardial leads with passive and active
fixation and the use of redundant loops of intravascular lead, led to an
increasing application of endocardial pacing. The reliability of endocardial
leads was tempered by concerns for venous obstruction and the potential for
venous access problems in the future if the lead had to be replaced 23. The
ability to advance leads with growth and new extraction techniques that
maintained vascular access despite occlusion around a redundant lead may
lessen these concerns. Figa et al. reported evidence of venous obstruction by
echocardiography and/or venography in 21% of 63 children and related this to
lead diameter and body surface area at the time of lead implantation 24.
Campbell and colleagues performed serial venographic evaluation in a subset
of 10 patients implanted with 4.5 F, bipolar, active fixation leads under the age
of 5 years. After 12 months follow-up, all ten patients showed evidence of at
least mild asymptomatic subclavian vein stenosis at the lead introduction sites.
Five patients also showed signs of collateral vein formation around this
stenosis but no thrombus formation or occlusions were observed 25.
There are few studies addressing specifically the challenges of pacing in the
< 10 kg infant whether via the epicardial or endocardial route. The only report
of epicardial pacing in this group is from Villaine et al in 34 neonates and
infants < 10 kg with non-surgical CHB 21. Of these, 15 received steroid and the
remainder non-steroid epicardial leads. There were 4 acute lead failures within
the first year of implantation – including 2 steroid lead failures within a
month – and one late lead fracture. In addition there were 2 pacemaker system
infections and 1 early generator depletion. The majority of these
complications of epicardial pacing were managed with an endocardial
replacement and the unit’s policy is now to electively place an endocardial
system at the end of life of the generator in all.
There is a similar paucity of long-term studies of endocardial pacing in very
small children. In 1990, Till et al reported on 24 children < 15 kg, of whom 11
< 10 kg, at the time of pacemaker implantation 4. Of these 6 needed an early
re-operation due to lead fracture, generator migration, infection or generator
depletion. There were no reports of venous obstruction though this was not
specifically sought. Stojanov reported 9 children < 10 kg at pacemaker
Chapter 7
90
implantation using a cephalic vein cut down but there was no follow up or
report of complications 26. There is also an abstract report of 7 children < 4 kg
undergoing dual chamber pacemaker implantation with unipolar leads via a
subclavian puncture. There was a subclavian vein thrombosis in a 1.2 kg
neonate and nearly all required lead advancement prior to generator end of
life 27.
In the current study, we have described the outcome of endocardial pacing in
39 children under 10 kg who were followed for up to 15.3 years (median 4.3
years).  Ten of them (28%) underwent a lead advancement, nine (25%) lead
extraction, and 12 (33%) an end-of-life generator replacement. Four patients
(11%) had an asymptomatic venous occlusion found during lead extraction,
three patients (8%) had initial wound closure problems and two patients (5%)
suffered a wound or lead related infection. Thus the challenges in this group
related to generator positioning and venous occlusion.
Despite use of the smallest generators that are currently available, there were
3/39 with a wound closure or erosion complication. None of these occurred
with primary abdominal implants where the subcutaneous tissue has more
bulk and the generator does not overly the bony thorax or in submuscular
pectoral implants where the muscle bulk gives better generator cover. The site
of implantation did not achieve statistical significance for wound
complications. While a faulty implantation technique may have been
responsible, there were confounding factors in 2 of these patients. The mother
of the one neonate had been treated with steroids for four months antenatally
to try reverse heart block/prevent hydrops and this may have influenced the
wound healing process. In the second neonate, the generator was resited in the
abdomen but 2 years later began to erode again. While this too may have been
due to an occult infection, this case has similarities with the patient reported
by Villaine et al who seemed to have an allergy to conventional pacemaker
material that required a specially coated pacemaker to prevent a third
recurrence – a factor not hitherto considered by us in our patient 21.
The advantage of the larger soft tissue bulk in the abdomen is far outweighed
by the effects on lead length during growth if the generator is not sited in the
pectoral region. Of the 4 leads that required lead advancement prior to
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generator end of life, 3 had been sited in the abdomen. The 4th resulted from
the inappropriate choice of a bulky bipolar lead that restricted the ability to
form an adequate intra-atrial loop in a 2.7 kg neonate. Encouragingly, the
excess intravascular lead that is looped in the atrium – some operators leave a
loop in the ventricle 28 – allows growth without distraction of the lead from
the ventricular endocardium. In some the lead needs to be advanced at the
first generator change but in others an adequate loop remains even after
considerable growth. Septal or right ventricular outflow tract placement of the
lead tip should theoretically allow more growth than leads placed in the right
ventricular apex but it was not possible to assess this in the current study as
only a minority of leads were not placed in the apex 2. It was our impression
that the smaller bodied unipolar leads were easier to advance but this too was
not rigorously tested in this study.
The most worrying aspect of this study was an incidence of 4/36 subclavian
vein occlusions (11%). All these children were < 4.6 kg at the time of
pacemaker implantation and had lead body diameters of 5.0 – 6.6 F. In
choosing leads for these children we did not always use the smallest lead body
diameters available at the time. We were swayed by the advantages of the very
small Microny generator, which initially required a bipolar lead (even though
pacing was unipolar) and traded off the increased lead body diameter with the
smaller generator. The latest version of the Microny allows a unipolar lead
that should reduce this problem. While an asymptomatic subclavian vein
occlusion around a functional lead in an adult may not affect clinical
management, the same cannot be said for a child with a lead that needs
replacing. Although extraction techniques are continuing to improve, and
often allow lead replacement through an occluded vein, it is not always
possible. We have avoided the use of countertraction and radiofrequency
sheaths in children < 25 kg preferring a modified technique described ealier.
Down sizing of extraction sheaths for smaller leads may allow their safe use
even in smaller children. Extrapolation of the data from Figa et al suggests
that a 4, 5 and 6 F lead should be accommodated by a 2.5, 5.0 and 8.0 kg child
respectively 24. As there were very few small children in their study this has not
been tested but confirms that the leads we chose to use were too big in those
< 5.0 kg. Currently smaller bodied leads are available and it is anticipated that
leads as small as 2F under development will become available and would be
ideal in this population 25.
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Endocardial pacemaker implantation is increasingly becoming the approach of
choice for children over 1 year of age or above 10 kg in weight. It is in the
smallest group – those < 10 kg in weight - that the most controversy exists.
The lack of reporting in this group and the absence of any trials has resulted
in the choice of the endocardial or epicardial approach being an empirical one.
Neither approach is free from complications. The current study demonstrates
that endocardial pacing in small children is feasible and effective. The
superiority of this approach, however, over epicardial pacemaker implantation
has not been demonstrated but it is an acceptable alternative. Use of the
smallest available leads and on going developments in this area is likely to
make endocardial pacing more widely acceptable. At present, the final choice
of an endocardial or epicardial approach in children < 10 kg in weight should
be based on the experience and expertise available in the unit treating these
patients.
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ABSTRACT
Objectives
To identify predictors for sudden death (SD) in patients with transposition
of the great arteries (TGA), having undergone atrial inflow repair.
Background
SD is the commonest cause of late death after atrial inflow repair of
TGA. Little is known about the predictors of SD. 
Methods
A retrospective multi-center, case-controlled study. We identified 47
patients after Mustard or Senning operation who experienced a SD event
(34 SD, 13 near miss SD). Each patient was matched with two controls with
the same operation, but without a SD event.
Information on numerous variables prior to the event was obtained and
compared with controls at the same time frame.
Results
Presence of symptoms of arrhythmia or heart failure at most recent follow-
up and history of documented arrhythmia (supraventricular tachycardia
(SVT) in particular) were found to increase the risk of SD. ECG, chest Xray,
and Holter ECG findings were not predictive of SD.  Neither medication
nor pacing was found to be protective.
Conclusions
Presence of symptoms and documented SVT are the best predictors of SD
in TGA patients. 
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INTRODUCTION
Before the 1980s, most patients with transposition of the great arteries (TGA)
were treated by atrial inflow correction using the Mustard’s or Senning’s
operation. Many children who underwent these operations are now adults.
While their survival rate has been good 1-7, arrhythmia, RV dysfunction and
late death are well recognized complications 1-9.   One cause of late death is
sudden death (SD) with an incidence of 2-15%  1-10.  In some studies, SD was
the commonest cause of late death 1,2,8.  Little is known about risk factors for
SD in this group of patients.
In an attempt to establish predictive factors for SD, we undertook a multi-
center, retrospective, case-controlled study.
METHODS
We included all patients who had undergone a Mustard or Senning operation,
and had suffered either SD or near miss SD from eight institutions. SD was
defined as acute unexpected cardiovascular collapse resulting in death or from
which the patient never regained consciousness 11.   Near miss SD was defined
as acute cardiovascular collapse with successful cardiopulmonary resuscitation
or documented appropriate implantable cardioverter defibrillator (ICD)
discharge. We excluded patients in severe heart failure who were considered
terminal and whose death was expected.  With these criteria we identified 47
SD cases (34 SD and 13 near-miss SD). This group of patients will henceforth
be referred to as sudden death (SD) cases. For each of the SD patients we
matched 2 control patients. Matching criteria were type of operation,
operation date within 3 years from corresponding SD case and age at
operation as close as possible to that of the corresponding SD case. Controls
were obtained from the same center as the corresponding SD case with the
operation having been performed by the same surgeon. According to these
criteria we were able to identify 93 suitable control patients (we were able to
find only one control for one of the SD cases). All medical records were
reviewed to obtain clinical data; Data from the last full assessment within 5
years of the event were used for analyses.  For controls, data collected
pertained to that which had been collected around the time of the event in the
corresponding SD case.
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All available electrocardiograms (ECG), chest Xrays, Holter 24 hr ECGs,
echocardiogram reports, exercise test reports, cardiac catheterisation and
electrophysiology study reports were reviewed.  Data collection was completed
in September 2002. The study was approved by the institutional review boards
of the participating centers.
Definitions
TGA was called simple if the ventricular septum was intact or when a small,
hemodynamically insignificant ventricular septal defect (VSD) was present.
Complex TGA was defined as the presence of a VSD requiring closure or
another lesion, such as ventricular outflow tract obstruction requiring surgical
intervention. Closed patent ductus arteriosus, aberrant vessels and repaired
coarctation of the aorta did not constitute ‘complex’.
Heart size measured on roentgenogram was divided into normal (CT ratio
≤ 50%), and enlarged (CT ratio >50 %). RV size on echocardiography, was
subjectively assessed as normal or enlarged from the echocardiography reports
from each institution. Likewise, RV function, was assessed as satisfactory,
moderately impaired or severely impaired. Exercise tolerance during exercise
tests was quantified as normal (100%), slightly decreased (80-100%),
decreased (60-80%) or poor (<60%), given as the percentage of the normal
value expected for age, bodyweight and gender. Sinus node disease (SND) was
defined as absence of sinus rhythm with presence of atrial or junctional escape
rhythm as dominant rhythm. Sparse sinus beats occurring within a dominant
escape rhythm was also considered  SND. Patients with paroxysmal episodes
of supraventricular tachycardia (SVT), whose underlying rhythm was sinus,
were not considered to have lost sinus rhythm. Frequent supraventricular or
ventricular extra systoles were noted as arrhythmia if >100 extra beats per
hour.
Statistical analysis
Descriptive statistics are reported as frequency, median or mean value and
range or standard deviations as appropriate. Data were analysed using SPSS
software for Windows.
Risk factors for SD event were identified by univariate conditional logistic
regression analyses. Results are reported as Odds ratios (OR) with 95%
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confidence intervals (CI) for significant predictors. (Table 3) Since many risk
factors were tested within the same data set, we considered a p-value of
<0.005 statistically significant.
Table 1.  Baseline characteristics
SD Cases (n = 47) Controls (n = 93)
No. (%) No. (%)
Male 35 (74,5%) 74 (79,6%)
Female 12 (25,5%) 19 (20,4%)
Simple TGA 36 (76,6%) 75 (80,6%)
Complex TGA 11 (23,4%) 18 (19,4%)
Pre-operative palliation
None 1 (2,1%) 2 (2,2%)
Rashkind balloon atrioseptostomy 39 (83%) 76 (81,7%)
Blalock Hanlon atrioseptectomy 11 (23.4%) 28 (30%)
Banding Pulmonary artery 2 (4.3%) 1 (1.1%)
Blalock Taussig shunt 0 (0%) 1 (1,1%)
Type of surgery
Mustard 42 (89.4%) 83 (89.2%)
Senning 5 (10.6%) 10 (10.8%)
Median age at surgery (years (range)) 1.1 (0-6.9) 1.2 (0-8.0)
Surgical era 1967-1993 1965-1989
Post-operative (<2 weeks) arrhythmia
None 17 (36.2%) 44 (47.3%)
Sinus bradycardia 0 (0%) 4 (4.3%)
Nodal rhythm 12 (25.5%) 16 (17.2%)
AV block 4 (8.5%) 4 (4.3%)
Supraventricular tachycardia 9 (19.1%) 4 (4.3%)
Cardiopulmonary arrest 0 (0%) 3 (3.2%)
Re-operations   9 (19.1%)   19 (20.4%)
Baffle repair 4 (8.5%) 13 (14%)
Enlargement Pulmonary venous drainage 3 (6.4%) 4 (4.3%)
Other 3 (6.4%) 8 (8.6%)
Numbers with respect to pre-operative palliation, post-operative arrhythmia and  re-operations
do not add up, because some patients had more than one intervention or arrhythmia.
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RESULTS
Baseline characteristics, preoperative palliation, early post-operative
arrhythmia and reoperations are shown in table 1.
Events
Thirty-four events (81%) occurred during exercise, 5 (12%) patients died
during sleep and 3 (7%) patients had a pre-existing sustained atrial flutter or
atrial fibrillation going on during 1 to 2 days prior to event.  For 5 of the 34
patients who died, no information was available regarding the circumstances
of their death.
Mean age at event was 12.3 years (median 9.7; range 0.3 – 32) and average
interval post-surgery 10.6 years (median 7.9; range 0.3 – 28.8) (Fig 1).  Thirty
of 47 events (64%) occurred <12 years after surgery.  No clustering in either
age or follow up time was found. Autopsy reports were available for 14
patients (41%) and are listed in table 2. For eight SD cases rhythm
documentation was available at time of event and showed ventricular
tachycardia (VT) or ventricular fibrillation (VF). Of the 13 patients with a
near miss SD, ten had documented VT or VF at time of the event. The other
three had loss of consciousness without pulsations felt by onlookers, and, in
all, cardiopulmonary resuscitation was successful, without need for
defibrillation.
Table 2.  Autopsy findings (n=14).
Autopsy findings N
Detached pacemaker lead 1
Pulmonary vein stenosis 1
Pulmonary vein stenosis with hypertension 1
One pulmonary vein to left lung 1
Fresh thrombus in little branch coronary artery and irreversible PHTN 1
Fresh thrombus in right coronary artery 1
Bronchopneumonia 2
Fibrosis around patch and conduction system 2
Left ventricular outflow tract obstruction 1
No abnormalities, except signs of right ventricular overload 3
PHTN = pulmonary hypertension.
Predictors Of Sudden Cardiac Death After Atrial Switch
101
Fo
llo
w
-u
p 
ti
m
e 
po
st
 s
u
rg
er
y 
at
ti
m
e 
of
 e
ve
n
t 
(y
ea
rs
)
SD case number
0 10 20 30 40 50
10
0
20
30
Figure 1. Scattergram of follow-up time post surgery at time of event (vertical axis) for the
SD Cases (horizontal axis). No clustering is found, indicating a continuous risk going on.
Seven out of 13 patients with near miss SD received either an ICD (n=4), or a
pacemaker (n=3).  Of the 3 receiving pacemakers, one had SND and two had
poor escape rhythm following medication to suppress arrhythmia.
Four patients, who suffered a near miss SD, died at follow up. Two died from
neurologic damage within 24 hours and 2 months respectively despite
regaining heart rhythm. One other patient died of VF while awaiting heart
transplantation 14 months after the initial event. The fourth patient died six
years after the initial event from an unknown cause.
Symptoms
Data regarding symptoms just prior to the event were available for 45 SD
patients and 92 controls.  Presence of symptoms (combined or analysed
separately as arrhythmic (palpitations and syncope) and heart failure
(recurrent upper respiratory tract infections, decreased exercise tolerance,
tiredness and shortness of breath) symptoms) was a significant risk factor for
SD (Table 3).
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Standard 12-lead electrocardiography
ECG’s were available for 44 SD cases and 84 controls. Twenty-six SD patients
(59%) showed sinus rhythm on ECG, as did 54 controls (64%) (Table 4)
(p=ns). Mean QRS duration, QT and QTc intervals and heart rate are listed in
table 4 and showed no difference between the two groups (Table 3). A QRS
duration of >100 ms was noted in  12 of 39 SD cases (31%) and  15 of 78
Table 3.  Variables for which conditional logistic regression analysis was performed, noted in
mean Odds ratios with 95% confidence intervals.
Symptoms P-value OR (95% CI)
Symptomatic * < 0.0005 6.45 (2.42 – 17.24)
- Arrhythmic symptoms * 0.003 21.60 (2.80 – 166.79)
- Heart failure symptoms * 0.001 4.44 (1.85 – 10.62)
ECG
- QRS time 0.723 0.32 (0.001 – 175.66)
- QT time 0.668 0.16 (0.000 – 734.27)
- QTc time 0.193 1084.50 (0.029 – 4.1 E+07)
- QRSd > 100 msec 0.251 1.980 (0.618 – 6.324)
- Heart rate 0.054 1.017 (1.000 – 1.035)
- Basal heart rhythm non-sinus 0.790 1.112 (0.509 – 2.427)
Thoracic X-ray
- Enlarged heart size 0.053 2.227 (0.989 – 5.000)
24-hours Holter
- Basal heart rhythm non- sinus 0.037 5.260 (1.10 – 25.00)
- Documented episodes of arrhythmia 0.431 1.770 (0.44 – 7.25)
- Mean heart rate 0.527 0.980 (0.919 – 1.044)
- Minimum heart rate 0.952 1.001 (0.956 – 1.050)
- Maximum heart rate 0.803 0.996 (0.965 – 1.028)
History of arrhythmia in follow up
- Documented arrhythmia * 0.005 3.473 (1.451 – 8.310)
- Documented SND in follow up 0.035 2.405 (1.065 – 5.432)
- Documented SVT in follow up * 0.001 4.866 (1.900 – 12.462)
Arrhythmia treatment
- Pacemaker implantation 0.550 0.641 (0.149 – 2.758)
- Medication treatment * 0.002 5.159 (1.863 – 14.283)
OR= Odds Ratio, CI = confidence interval, SND = sinus node disease, SVT = supraventricular
tachycardia. * Statistically significant risk factor (p < 0.005).
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control patients (19%) (ventricular paced patients were excluded from this
analysis). This was not statistically significant (Table 3).
Holter 24-hours ambulatory ECG monitoring
Holter 24 hour ECG was available in 26 SD cases and 40 controls.  The
dominant heart rhythm on Holter is shown in table 4.  Presence of non-sinus
rhythm at just failed to reach statistical significance as risk factor for SD
(Table 3).
Forty-two percent (11 of 26) SD cases and 23% (9 of 40) controls showed
episodes of arrhythmia on Holter, which are listed in table 5. This difference
was not statistically significant (Table 3). The mean of the mean, minimum
and maximum heart rates on 24-hours holter recording was similar for the
two groups (Table 4).
Table 4.  Basal heart rhythm and mean variables on electrocardiogram and 24-hours Holter
recording prior to event.
ECG 24-uurs holter
SD Cases Controls SD Cases Controls
(n = 44) (n = 84) (n=26) (n=40)
Sinus rhythm 26 (59,1%) 54 (64,3%) 9 (34,6%) 26 (65%)
AV junctional rhythm 10 (22,7%) 19 (22,6%) 3 (11,5%) 1 (2,5%)
Atrial rhythm 2 (4,5%) 3 (3,6%) 12 (46,2%) 13 (32,5%)
SVT 1 (2,3%) 1 (1,2%) 1 (3,8%) 0 (0%)
VT 1 (2,3%) 0 (0%) 0 (0%) 0 (0%)
VVI paced 3 (6,8%) 4 (4,8%) 1 (3,8%) 0 (0%)
AAI paced 1 (2,3%) 3 (3,6%) 0 (0%) 0 (0%)
Mean ECG variables
QRS time (msec) (range) 98.8 (60-200) 93.8 (50-160)
QT time (msec) (range) 367 (240-530) 377 (240-490)
QTc time (msec) (range) 426 (340-550) 413 (210-500)
Heart rate (bpm) (range) 88 (38-150) 76 (43-150)
Mean Holter variables
Mean heart rate (bpm) (range) 73 (40–110) 75 (61-100)
Minimum heart rate (bpm) (range) 48 (26–80) 46 (30-70)
Maximum heart rate (bpm) (range) 149 (100–240) 150 (70-190)
SVT = supraventricular tachycardia; VT = ventricular tachycardia, bpm = beats per minute
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Chest XRay
Chest Xrays were available for 42 SD patients and 77 controls. In 31 SD cases
(64%) and 40 (52%) of controls, the heart size was enlarged (p=ns, Table 3).
Echocardiography
Echocardiography data are listed in table 6. RV size was similar for SD cases
and controls. SD cases, however, tended to have a more impaired RV function
and slightly more tricuspid regurgitation than controls.  The incidence of
baffle obstruction, as identified by echocardiography, was similar for the two
groups.  The paucity of available echocardiograms prevented us from
performing reliable statistical analysis.
Cardiac catheterisation
Data on cardiac catheterisation are listed in table 7. Two of the SD cases and
two of the controls with mild systemic venous baffle obstruction and one
control patient with pulmonary venous obstruction subsequently underwent
baffle repair. Two out of four control patients with a baffle leak underwent
repair. Two of the SD patients with an obstruction, were also found to have a
baffle leak.
Only 12 electrophysiology studies (two SD cases; ten controls) were
performed.  Both SD case patients showed SND. Control patients showed
Table 5.  Documented episodes of arrhythmia on 24-hours Holter recording.
SD Cases (n=26) Controls (n = 40)
SVT 3 (12%) 1 (3%)
Sinus arrest 1 (4%) 4 (10%)
Sinus rhythm with junctional escape at rest/night 1 (4%) 4 (10%)
Frequent SVES 3 (12%) 0 (0%)
Frequent VES 1 (4%) 0 (0%)
VT 2 8%) 0 (0%)
SVT = supraventricular tachycardia, SVES = supraventricular extra sustolies, VES = ventricular
extra systolies, VT = ventricular tachycardia.
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Table 6.  Echocardiography results.
SD Cases Controls
No. (%) No. (%)
Right ventricular size n=22 n=40
Normal 1 (4.5%)    2 (5%)
Enlarged    21 (95.5%)    38 (95%)
Right ventricular function n=19 n=31
Satisfactory    5 (26.3%)    16 (51.6%)
Mildly-Moderate impaired    9 (47.4%)    14 (45.2%)
Severely impaired    5 (26.3%)    1 (3.2%)
Tricuspid regurgitation n=18 n=42
Absent    4 (22.2%)    19 (45.2%)
Mild    8 (44.4%)    18 (42.9%)
Moderate    2 (11.1%)    3 (7.1%)
Severe    4 (22.2%)    2 (4.8%)
Baffle obstruction n=15 n=38
Absent    13 (86.7%)    31 (81.6%)
Present    2 (13.3%)    7 (18.4%)
SND alone (n=3), AV node dysfunction (n=1), SND plus AV node dysfunction
(n=3) and inducible VT (n=1).  Two controls had a normal electrophysiology
study.  No statistical analysis was performed on the catheterisation and
electrophysiology data, due to small numbers.
Exercise testing
Data on exercise capacity are listed in table 8.  Arrhythmias were induced
during exercise in 5 (38%) SD cases and 9 (24%) controls, including atrial
flutter degenerating into VF in one SD patient.  The others had junctional
rhythm (2 SD cases and 7 controls) or ventricular ectopy (2 SD cases and 2
controls) either during exercise or during the recovery phase.
Statistical analyses could not be performed on exercise test data due to small
numbers.
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Arrhythmia during follow up
Of the 47 SD cases, 34 (72%) had a documented arrhythmia prior to their
event, in contrast to only 47 of 93 controls (51%).  Presence of arrhythmia
was a significant risk factor for SD (Table 3). The different arrhythmias are
listed in table 9. SVT constituted atrial flutter or fibrillation. Presence of SND
barely approached significance (Table 3), but presence of prior documented
SVT was a significant risk factor for a SD event (Table 3).
In 15 SD cases (30%) and nine controls (10%) more than one arrhythmia was
diagnosed. Twenty-eight SD cases suffered SND and of these 14 (50%) also
had SVT. One SD patient with SND had frequent ventricular extrasystoles. Of
the 41 controls with SND, nine (22%) also had documented SVT (Table 9).
The mean interval between surgery and first arrhythmia was 4.0 years (range
0-22.3 years) for SD cases and 3.7 years  (range 0-15.6 years) for controls. The
mean interval between the first episode of arrhythmia and SD event was 7.2
years (range 0.5 – 27.4 years) in the SD group. No association was found
between the occurrence of sudden death and the time of onset of arrhythmia.
Table 7.  Cardiac catheterisation.
SD Cases (n=16) Controls (n = 27)
No. (%) No. (%)
Normal 6 (38%) 10 (37%)
Mild systemic baffle obstruction 4 (25%) 5 (19%)
Mild pulmonary venous obstruction 1 (6%) 2 (7%)
Mild systemic and pulmonary venous obstruction 1 (6%) 0 (0%)
Baffle leak 3 (19%) 4 (15%)
Left ventricular outflow tract obstruction 1 (6%) 5 (19%)
Abnormal lungvein drainage into SVC and 1 (6%) 0 (0%)
collaterals from aorta to right lung
Calcification conduit LV to PA 1 (6%) 0 (0%)
Patent ductus arteriosus 0 (0%) 1 (4%)
SVC = superior vena cava, LV = left ventricle, PA = pulmonary artery
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Table 8.  Exercise testing.
Exercise capacity SD Cases (n=13) Controls (n = 38)
No. (%) No. (%)
Normal 2 (15%) 8 (21%)
Slightly decreased 5 (39%) 19 (50%)
Decreased 2 (15%) 9 (24%)
Bad 4 (31%) 2 (5%)
Arrhythmia treatment
Pacemaker implantation
Eight SD cases (17%) and fifteen controls (16,1%) had a pacemaker, which
was implanted at average follow-up post-surgery of 12.1 years (range 0.1-26.1
years) for SD cases and 8.6 years (range 0-24.3 years) for controls. Although
controls tended to get a pacemaker implanted earlier, statistical analysis could
not be performed due to small numbers.
Seven of eight SD cases received a pacemaker for SND, as did 14 of 15
controls. The others (one SD and one control) had complete AV block.
Pacemaker implantation turned out to have no protective value against SD
(Table 3).
Cardiac medication
At time of event, 20 SD patients (43%) and 17 controls (18%) were using
cardiac medication. Of the 20 SD patients, 18 were on digoxin (4 also on
verapamil and 1 also on betablocker) and 2 were on betablocker. Of the 17
controls, 9 were on digoxin (2 of whom were also on betablocker), 3 on
verapamil, 2 on sotalol and 1 on amiodarone.  Two (2%) were using an ACE
inhibitor. The use of cardiac medication appeared to increase the risk for a SD
event (Table 3).
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DISCUSSION
Oechslin and colleagues found that in a large cohort of adult survivors with
congenital heart disease, SD was the most common cause of late death 12. In a
population based study, Silka et al. reported a 25-100 fold increase in risk of
late SD for patients operated for common congenital heart defects relative to
age-matched controls. Together with aortic stenosis, aortic coarctation and
tetralogy of Fallot, surgically corrected transposition of the great arteries was
one of the congenital heart defects in which the majority of sudden cardiac
deaths occurred 11. In their report there were 7 SD among 172 TGA patients,
giving an incidence of 4.9/1000 patient-years.
A number of studies have looked at the long-term problems occurring after
Mustard/Senning repair of TGA.  The main long-term sequelae are baffle
obstruction, arrhythmias (particularly SVT), systemic right ventricular
dysfunction, and SD.  The incidence of SD reported by various studies has
ranged from 2 to 15% 1-9.   Studies have shown SD to be the most important
cause of late death 1,2,8.
An adequate surgery database had been maintained in only five of the eight
participating centers in our study.  In those five centers, a total of 582 Mustard
or Senning operations have been performed with a mean SD incidence of 6%.
The incidence of SD was different for each of these five centers, ranging
between 3% and 11%. Out of the 47 SD cases in our study population, five SD
cases had undergone a Senning operation and 42, a Mustard’s operation.
Although we haven’t performed a direct comparison in our study, this finding
Table 9.  Documented arrhythmia in follow up.
Exercise capacity SD Cases (n=47) Controls (n = 93)
Sinus node disease 28 (60%) 41 (44%)
SVT 18 (38%) 13 (14%)
Sinus node disease together with SVT  14 (30%)   9 (10%)
Complete AV block 1 (2%) 2 (2%)
Frequent VES 2 (4,3%) 0 (0%)
Sinus node disease together with frequent VES   1 (2%)   0 (0%)
SVT = supraventricular tachycardia, VES = ventricular extra systolies
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probably reflects the superior outcome for the Senning operation when
compared to the Mustard operation as reported by several authors 4,5,10.
Not much is known about risk factors for SD in the Mustard and Senning
population since few studies have addressed this issue.  Our study found
presence of symptoms and presence of documented SVT (mainly atrial
flutter) to be associated with risk of SD.  Interestingly, both arrhythmic and
heart failure symptoms were associated with SD. Use of cardiac medications
was also a risk factor.  It is not possible to say whether this indicates that
patients on medications were a sicker group or whether this represents a
negative side effect of the drugs themselves.
Arrhythmias
SVT, in particular atrial flutter, has been identified as a predictor of sudden
cardiac death by others. Flinn et al. reported 9 SD among 372 survivors and
showed a weak association between atrial flutter and SD 3. Sarkar et al.
reported that documented atrial flutter resulted in a 21-fold increase in the
risk of late SD 4. In contrast Gelatt and colleagues could not find a relationship
between the incidence of atrial flutter and SD 1. Janousek et al. studied 359
patients after Mustard/Senning operation 13. Fifteen patients (4.2%) died
suddenly.  By multivariate analysis, they found severe tricuspid regurgitation
and/or RV dysfunction and medically uncontrolled SVT to be the risk factors
for SD. Our findings suggesting that heart failure symptoms and documented
supraventricular arrhythmia may be risk factors for SD are somewhat similar
to those of Janousek et al. It is difficult to determine whether arrhythmia is
the cause or the effect of ventricular dysfunction.  To date there is no study
(including ours) which has been able to determine which of these factors is
primary.
As early as 1972, El-Said remarked on the frequent occurrence of arrhythmias
after the Mustard operation 14.  Other reports soon confirmed that both
bradyarrhythmias (primarily due to sinus node dysfunction) and
tachyarrhythmia (primarily atrial flutter) were significant problems after the
Mustard/Senning approach for TGA 15-17. There is a continued risk of sinus
node disease despite modification of surgical techniques 3,5,17-19. However
bradyarrhythmias appeared to be less important than tachyarrhythmias where
mortality was concerned 1,3,8,9.
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Bink-Boelkens et al. showed that even asymptomatic children after the
Mustard operation have significant electrophysiologic abnormalities of the
sinus node 18. In our study 44% of the controls and 60% of the SD cases had
documented SND. Of the 28 SD patients with SND, 14 (50%) also had
documented SVT, as had nine of the 41 controls with SND (22%). Like others,
our study showed no association between SND and risk for SD 5,8,19.
As shown by others, pacemaker implantation had no influence on the risk of
sudden cardiac death in our study 3.
Symptoms
We found the presence of symptoms to be a risk factor for SD. Previous
studies have not reported this association.  Indeed, Gewillig et al. found that
functional status or lack of symptoms had no prognostic value for late death
(including hospital and non-cardiac deaths) 8. In our series, only 33% of the
SD cases were symptom-free prior to their event, compared to 71% of the
controls. Arrhythmic symptoms such as palpitations, dizziness and syncope
increased the risk for sudden cardiac death by a factor of 21.6 (95% CI of 2.80
to 166.8).   There was a high association between the occurrence of
documented arrhythmia (a separate risk factor for SD) and arrhythmic
symptoms (Pearson Chi-square = 10.0; p = 0.002). Heart failure symptoms
resulted in a 4.4-fold increase in the risk for a SD event.
Right ventricular function
Right ventricular failure has been shown to be a risk factor for late death in
Mustard and Senning patients 1,6,8. Janousek and colleagues have been the only
ones who have also demonstrated a relationship between RV failure and SD in
this patient group 13. Whether RV failure causes, or is caused by SVT is
unclear. Millane et al. have shown that perfusion and wall motion
abnormalities are common in the systemic RV late (10 to 20 years) after
Mustard’s operation and postulated this to be the cause of systemic RV
dysfunction 20. Poor ventricular function causes RV enlargement and
progressive tricuspid regurgitation, resulting in atrial volume and pressure
overload. This atrial overload may contribute to the development of
arrhythmias 1,21. In this context, Gatzoulis et al. showed the occurrence of atrial
flutter often following right ventricular failure, identifying atrial flutter as
surrogate marker for right ventricular failure 21.
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We were unable to show an association between right ventricular function and
SD because few patients had undergone adequate echocardiography or
catheterisation.
QRS dispersion and duration are reported as markers of inhomogeneity of
ventricular depolarisation and as predictor of dangerous arrhythmias and
sudden cardiac death in patients with tetralogy of Fallot 22,23. In Mustard
patients QT dispersion was identified as predictor of clinical arrhythmia 21.
We were unable to measure QRS and QT dispersions.  However, we did not
find any differences with respect to QRS, QT- or QTc times between SD cases
and controls. Unlike for tetralogy of Fallot, we were unable to demonstrate a
relationship between QRS width and the risk for SD although both anomalies
have a RV dilatation 23.
Of the seven SD in Silka et al’s study, five died during active physical exertion 11.
In our study, of the 47 SD events , 34 (81%) occurred during physical exercise.
From a hemodynamic perspective, the atrial inflow repair of TGA suffers
from two main drawbacks.  Firstly, the systemic RV seems intrinsically
suboptimal compared to the LV 24. Secondly, the absence of an adequate
capacitance chamber, (namely the atrium) which has been replaced by a baffle,
inherently imposes limits to ventricular filling 25. Exercise poses specific risks,
because these patients may not be able to augment cardiac output in the face
of rising demand due to the above-mentioned two factors. Given these
limitations, it is possible that occurrence of an arrhythmia during exercise will
cause further deterioration leading to death.  In addition, this inability to
adequately increase cardiac output may be amplified by coexisting baffle
obstruction, pulmonary vein stenosis or ventricular disease.
These findings stress the importance of an adequate diagnosis and treatment
of the above mentioned complications. Since presence of atrial flutter could
function as surrogate marker for these structural problems, hemodynamic
assessment is indicated in patients presenting with arrhythmia.
Exercise testing can identify patients with inadequate cardiac output 21. A
review of four studies demonstrated that an average of 61% of the
asymptomatic Mustard and Senning patients had abnormal ventricular
function when challenged with exercise 26. In our study, only eight out of 38
controls (21%) and two out of 15 SD cases (13%) were reported to have
normal exercise capacity. In one of the SD cases ventricular fibrillation was
induced during exercise testing. These numbers were too small to perform
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statistical data-analysis. However Meijboom et al indicated exercise capacity to
correspond well with the patients health self assessment, increasing the
importance of the presence of symptoms 27.
Silka et al. reported that each of the seven SD in their study was due to an
arrhythmia 11. They had ECG documentation during the event in four patients
and all showed either polymorphic VT or ventricular fibrillation (VF) as the
terminal rhythm 11.  In our group with near-miss SD (n=13), ten had
documented VT or VF during their event as had the eight patients who
suffered SD (n=34) for whom rhythm documentation at time of event was
available. Thus, polymorphic VT or VF seems to be the final rhythm in most
cases of SD where rhythm documentation is available.  We demonstrated that
routine follow-up ECG’s or 24-hours Holter recordings showed few rhythm
disturbances and were consequently of little help identifying patients at risk.
Scagliotti and colleagues postulated that inducible polymorphic VT at
electrophysiology study may be a marker for SD and advocated the use of
electrophysiology studies as a risk-stratifying test in these patients 28.  No study
to date has further explored this hypothesis. An important finding in our
study was the fact that the majority of patients in whom the rhythm had been
documented during the SD event had either VT or VF. In view of this, we
would recommend undertaking EP study for inducible VT/VF in patients
presenting with symptoms, in whom no arrhythmia has been documented.
Where VT/VF is inducible using moderately aggressive pacing protocols, an
ICD should be considered.
Therapy
We identified SVT as a risk factor for sudden cardiac death.  Digoxin had no
protective value in our study population.  This finding argues for an
assessment of other therapies for SVT control/cure.  There has been recent
interest in the use of catheter ablation in critical zones of slow conduction as a
means of controlling atrial flutter in these patients 29-32. Future studies could
determine the impact of this strategy on the incidence of arrhythmia and SD.
However, since SVT may be secondary to ventricular dysfunction, the role of
RF catheter ablation in these patients is questionable.
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Study Limitations
This study has limitations inherent to any retrospective study, limiting data
collection to variables available from clinical records. Decisions on cardiac
testing were based solely on clinical grounds and were not standardised for the
different patients. The participation of eight different centers with different
approaches to management and follow up made it difficult to obtain uniform
data. If a SD case patient developed an arrhythmia after the last clinical visit
and before event, this would have been missed and could potentially lead to
underestimation of the importance of an arrhythmia.
We have chosen to perform this study in a case-matched control setting. Such
a design is open to criticism when data on pertinent variables are not available.
In our study this limitation results for certain pieces of data being available in
only small subsets of patients with consequently inability to perform statistical
comparisons. We have not described data on operation technique. Several
studies have shown that the type of operation, the year of birth and era of
operation influence late outcome in Mustard and Senning patients 9,10. To
exclude the influence of these factors, we have matched our SD cases and
controls for these variables and have in addition constituted our SD case-
control sets operated and followed up in the same center.
Conclusions
Presence of symptoms of arrhythmia or heart failure and presence of
documented SVT are the best predictors of SD in patients who have survived
a Mustard or Senning operation. It is not possible to say whether SVT directly
contributes to SD or is merely a marker for it.  Further study with larger
patient cohorts may help us whether any specific tests, such as an
echocardiogram, cardiac catheterisation, and particularly exercise testing or
electrophysiology testing can improve the accuracy of identifying patients at
risk for SD.
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TACHY-ARRHYTHMIAS
Over the past decade, management of tachyarrhythmias in children has
evolved remarkably. In particular the introduction of radiofrequency catheter
ablation (RFCA) in the pediatric population has been a major contribution to
this development. This possibility to cure children of their arrhythmia as an
alternative to chronic anti-arrhythmic drug therapy clearly represents an
advance in medical management.
In chapter 2 we describe the experience with RFCA in paediatric patients in a
university hospital. Sixty-four patients who had undergone catheter ablation
for the more common tachy-arrhythmia substrates were enrolled. The
majority of these children either had atrioventricular re-entrant tachycardia
(n=38) or atrioventricular nodal re-entrant tachycardia (AVNRT) (n=14). In
all but one patient with AVNRT, successful abolition of their arrhythmogenic
substrate was achieved after RFCA. Twelve other children underwent RFCA
for less common tachyarrhythmias, including ventricular tachycardia, ectopic
atrial tachycardia and intra-atrial reentrant tachycardia. The ablation
procedure was successful in nine of them (75%). Procedure related
complications occurred in two patients (3%). We conclude that RFCA is a safe
and effective alternative therapy to anti-arrhythmic drugs for the treatment of
tachyarrhythmia in children.
The technical difficulties associated with manipulating catheters in small
hearts in combination with the application of radiofrequency (RF) lesions
raise concerns for potential  post-ablation complications in children. The
major complications, such as permanent atrioventricular block or cardiac
perforation are likely to be recognised immediately. In order to assess
potential subclinical complications, echocardiography was routinely
performed in children undergoing an ablation procedure. The clinical value of
a routine post-procedure cardiac echo in children had not been evaluated and
was therefore studied in chapter 3. In this study, 138 patients undergoing
ablation had transthoracic echocardiograms before and after ablation. We
detected one asymptomatic complication requiring medical intervention and
three asymptomatic disorders that resolved spontaneously. Our results suggest
that routine transthoracic echocardiograms are not indicated for the majority
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of children undergoing a straightforward catheter ablation for atrioventricular
tachyarrhythmias. An exception could be made for children in whom the
retrograde approach has been used for a left-sided ablation, in order to
specifically assess the aortic valve function.
In the next two chapters we concentrate on two rare forms of arrhythmia.
Chapter 4 describes two patients with silent atrium, who experienced
coexisting episodes of intra-atrial re-entrant tachycardia. Successful catheter
ablation of the intra-atrial re-entry circuits led to improvement of cardiac
function. Little is known about silent atrium and as long as the natural history
is poorly understood, ablation of the His bundle should not be the initial
therapeutic option for intraatrial reentrant tachycardia associated with this
entity. In one of our patients, atrial electrical and mechanical function
recovered during follow-up. Our data suggests that even when the atrium
appears electrically to be silent, as seen by absence of a P wave on the ECG,
islands of electrically active atrial tissue are present, which may contribute to
reentrant circuits within the atrium.
Previous studies suggest that familial inherited forms of the disease may exist.
Further research in these areas will help to increase our understanding of this
disease and its long-term prognosis.
Another type of atrial arrhythmia is discussed in chapter 5. Although many
electrophysiologists continue to use the term atrial tachycardia, it has been
shown that this group of arrhythmias can have numerous mechanisms. We
describe a form of focal atrial tachycardia, of which the mechanism remains
unclear. In general, automatic focal tachycardia cannot be induced in the
electrophysiologic laboratory. In this chapter we characterised 38 patients with
a non-automatic focal atrial tachycardia, that was inducible in the laboratory.
We found that this arrhythmia predominantly affects women in all age-groups,
that most of the tachycardia foci were located in the right atrium and that
younger patients had shorter tachycardia cycle lengths when compared to the
older patient group. Catheter ablation of the foci was possible, though with
success rates lower than generally reported for supraventricular tachycardia
ablation. We also compared catheter ablation aided by an electroanatomical
mapping system versus ablation without this specialised mapping system.
While the number of successfully ablated foci tended to increase with the use
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of this mapping system, we could not demonstrate either a shortening of
procedure time or a decrease in fluoroscopy time. Future studies should
determine whether the procedure and fluoroscopy times would decrease with
growing experience with the new mapping techniques.
The development of different mapping systems has given a further impulse to
the possibilities of catheter ablation. The more advanced mapping
technologies make complex arrhythmia substrates amenable for catheter
ablation. In chapter 5 we have discussed the use of electroanatomical mapping
in catheter ablation of non-automatic focal atrial tachycardia. In chapter 6 we
describe the use of another specialised mapping system, LocaLisa, in catheter
ablation of AVNRT in children. Twenty-six patients less than 19 years old with
structurally normal hearts and symptomatic AVNRT underwent catheter
ablation of their arrhythmia. Modification of the AV node slow pathway was
performed. Three of the 26 patients in whom AVNRT was not inducible after
RF ablation had recurrence of tachycardia and underwent a second successful
ablation procedure. In one child a second degree AV block complicated the
procedure. This however resolved spontaneously six weeks later.
The LocaLisa mapping system improves the safety and efficacy of slow
pathway modification in young patients in two ways. Firstly, by the possibility
to measure the distance of each RF ablation site to the proximal His bundle.
Secondly, by a continuously displayed relation of the ablation catheter tip-
electrode to the AV node and His bundle on the LocaLisa monitor. It is not
clear however whether such an aggressive approach of slow pathway
modification may have deleterious effects on AV node function in the future.
Late PQ prolongation and even AV block have been described in adult patients
following modification of the AV node. To date, we have not seen any
progressive AV block in our patient population.
In conclusion, in chapters 2-6, we demonstrate that radiofrequency catheter
ablation in children is a safe and effective therapy for tachyarrhythmia
treatment with a low complication rate. However, we need to realise well that
our follow up time is relatively short. It is not known, for example, whether
scars produced in the immature heart by RFCA, may themselves be the focus
for new arrhythmia substrates in adult life. Given on the one hand that RF
ablation appears to be feasible, safe and effective in young patients, and on the
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other hand concerns exist about the long-term effects of RF lesions in the
immature heart, it is important to establish guidelines for which child should
be considered for catheter ablation as opposed to treatment with anti-
arrhythmic agents.
The indications for catheter ablation in children have evolved over the past
decade. Responsible for this process are the technological advances in catheter
technology, the development and improvements of specialised mapping
systems and the increasing experience with RFCA for complex arrhythmia
substrates. We have performed one comparative and one descriptive study on
specialised mapping systems. To show improvement of RFCA results caused
by the use of specialised mapping systems, one should perform a prospective
randomised comparative study. This however will be difficult to set up for
ethical reasons. An alternative could be to compare fluoroscopy and procedure
times in combination with RFCA results for the different arrhythmias in
retrospect. However such a study design would exclude the learning curve for
any new system. Another confounding factor would be that with the
contribution of new mapping systems, more difficult arrhythmia substrates
are being treated with catheter ablation, which in the past would not have
been considered for this therapy.
BRADY-ARRHYTHMIAS
Also paediatric pacing has evolved over the past decade. Technological
advances in the development of smaller leads, steroid eluting leads and
smaller generators have clearly improved pacing therapy in children. In adults,
endocardial pacing is extensively used, while many children are still
epicardially paced. The reason for this is that in children the smaller patient
size rises concerns for a high risk of venous occlusion with endocardial pacing.
Particularly in this young patient group with potential requirement for life-
long pacing, one is in general very cautious in order to safe the veins as access
for pacemaker leads in later life. This results in a preference for the epicardial
approach in the paediatric population.
In chapter 7 we describe a follow-up study on a large series of transvenous
pacemaker implantation in children under 10 kg. Our results suggest that
endocardial pacing is effective and feasible in children under 10 kg, though not
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free from complications. We enrolled thirty-nine children from two centers
who had undergone implantation of a transvenous pacing system over the
past 15 years. The majority underwent pacemaker implantation for either
congenital complete heart block or surgically acquired complete heart block
following repair for congenital heart disease. Good pacing and sensing
thresholds at implantation were achieved in all cases. Follow up for 36 of
these children ranged from nine months to 15.3 years (median 4.3 years).
Sixteen patients (44%) (with a mean follow up of 28 months) did not undergo
any re-intervention during this period. Ten others (28%) had a system revision
at end of life of the generator at a mean of 61 months post initial
implantation. Finally, ten (28%) patients underwent a re-intervention prior to
the generator end of life. In three of them, this was because of generator
pocket problems and four others required a pacemaker lead advancement,
because the lead had stretched out. This latter problem is inherent to putting
pacemakers in a very small patients, no matter whether they are endo- or
epicardially implanted. The same applies for the generator pocket problems,
which might be partly overcome by putting all generator pockets abdominal.
These percentages and mean follow up times at time of re-intervention appear
very reasonable and suggest transvenous pacemaker implantation in children
to be feasible and effective.
However, during re-intervention, four asymptomatic patients (11%) were
found to have venous occlusion. Since these occlusions were noticed in
asymptomatic patients during four out of 12 lead advancements and 11 lead
extractions, this number of occlusions will probably be underestimated.
Further research is needed to define the exact occlusion rate, also in
asymptomatic patients not undergoing an intervention.
To make transvenous pacing more widely acceptable in small patients, the
number of patients with venous occlusion (11%) needs to be reduced. We
need to find out which patient groups under ten kilograms are at higher risk
to develop venous occlusion. The development of smaller leads could
contribute to decrease the occlusion rate. It is also likely that newer catheter
based technologies, such as the use of laser sheaths, which have already found
application in adult practice, will be extended to the pediatric population, and
will thereby enable occluded veins  to be recanalised and reutilised.
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DYSRHYTHMIAS POST-SURGERY
The improvements in outcome of cardiac surgery for congenital heart disease
have resulted in a growing population of surviving adolescents and adults who
have undergone cardiac surgery during childhood. This patient group suffers
from its own problems and risks. After surgical repair of certain congenital
heart defects, a considerable risk for the occurrence of sudden cardiac death
has been reported. Chapter 8 describes a study in which we tried to determine
risk factors for sudden cardiac death after atrial repair for transposition of the
great arteries. In this multi-center study, we enrolled 47 patients who had
undergone an atrial switch (Mustard or Senning) operation and had died
suddenly or had experienced near-miss sudden death at follow-up. Each of
these 47 patients was matched with two control patients each having
undergone the same type of repair, but who had not died suddenly.
Information on numerous variables recently before event was obtained and
compared with the corresponding controls. The presence of symptoms of
arrhythmia or heart failure was associated with risk of sudden death. In
addition a history of documented arrhythmia and in particular
supraventricular tachycardia appeared to increase the risk for sudden death.
Neither medication nor pacemaker implantation had a protective effect. This
finding argues for assessment of other therapies to control arrhythmias in this
patient population. Future studies should evaluate the impact of improved
techniques of RFCA in the Mustard/Senning population on the control of
arrhythmia and incidence of sudden death. On the other hand  the role of
catheter ablation might be questionable in these patients since it has been
shown that supraventricular tachycardia can cause ventricular dysfunction, but
can also be caused by ventricular dysfunction. ECGs, 24-hours Holter
recordings and chest X-rays are not of predictive value for sudden death.
Further study with larger patient cohorts may help to improve risk
stratification in patients with symptoms or a history of arrhythmia.
HARTRITME STOORNISSEN BIJ KINDEREN
Diagnostiche en therapeutische aspecten
Algemene Samenvatting en Discussie
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TACHY-ARITMIEËN
De afgelopen tien jaar heeft de behandeling van tachy-aritmieën bij kinderen
zich aanzienlijk ontwikkeld. Aan deze ontwikkeling heeft met name de
introductie van radiofrequentie catheter ablatie (RFCA) bij kinderen een grote
bijdrage geleverd. Deze mogelijkheid om kinderen te genezen van hun
ritmestoornis als alternatief voor het chronisch gebruik van anti-aritmische
medicatie is een grote vooruitgang op het gebied van de behandeling van deze
aandoening.
In hoofdstuk 2 beschrijven we de ervaringen met RFCA bij kinderen onder de
18 jaar in een Academisch ziekenhuis. Deze studie beschrijft 64 patiënten die
een catheter ablatie procedure voor hoofdzakelijk minder gecompliceerde
vormen van tachy-aritmie hadden ondergaan. De meeste van deze kinderen
hadden een atrio-ventriculaire re-entry tachycardie (n=38) of een atrio-
ventriculaire nodale re-entry tachycardie (AVNRT) (n=14). RFCA was
succesvol in het verwijderen van het aritmogene substraat bij 51 van deze
patiënten. In één patiënten met een AVNRT faalde de ingreep. De twaalf
overige kinderen ondergingen RFCA voor meer complexe tachy-aritmieën,
zoals ventriculaire tachycardie, ectopisch atriale tachycardie en intra-atriale re-
entry tachycardie. De ablatie procedure was succesvol bij negen van hen
(75%). Complicaties gerelateerd aan de ingreep kwamen voor in twee
patiënten (3%). Wij concluderen dat RFCA als behandeling voor
hartritmestoornissen bij kinderen een veilige en effectieve therapie is als
alternatief voor anti-aritmische medicatie.
RFCA bij kinderen heeft een potentieel verhoogd risico op complicaties in
vergelijking met volwassenen. Ten eerste vereist het nauwkeurig manipuleren
van catheters in een klein hart grote technische vaardigheid en ten tweede
worden radiofrequentie (RF) laesies aangebracht in een niet volgroeid hart
met onrijp myocard. Grote complicaties, zoals een compleet AV blok of een
hartperforatie, zullen naar alle waarschijnlijkheid onmiddellijk ontdekt
worden. Met het doel eventuele complicaties die zich klinisch niet uitten op te
sporen, werd in alle kinderen die een ablatie ondergingen, routinematig een
echocardiogram verricht. De klinische waarde van deze routine-echo na iedere
procedure was nog niet eerder geëvalueerd en werd daarom bestudeerd in
hoofdstuk 3. In deze studie werd bij 138 patiënten die een ablatie ondergingen,
een trans-thoracaal echocardiogram gemaakt vóór en na de ablatie procedure.
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De resultaten van deze studie laten zien dat een routinematig uitgevoerd
echocardiogram na iedere ablatie, niet geïndiceerd is voor de kinderen, die een
ongecompliceerde ablatie procedure hebben ondergaan voor een atrio-
ventriculaire ritmestoornis. Een uitzondering hierop, zou gemaakt kunnen
worden in het geval de retrograde benadering is gebruikt voor een linkszijdige
ablatie, zodat specifiek de aortaklepfunctie beoordeeld kan worden.
In de volgende twee hoofdstukken concentreren we ons op twee zeldzamer
vormen van ritmestoornissen.
Hoofdstuk 4 beschrijft twee patiënten met een stilstaand atrium die eveneens
perioden van intra-atriale re-entry tachycardie hadden. Succesvolle ablatie van
het intra-atriale re-entry circuit leidde in beide patiënten tot een verbetering
van de hartfunctie. Er is weinig bekend over stilstaand atrium en zolang het
natuurlijk beloop van deze aandoening nog niet volledig bekend is, mag
ablatie van de bundel van His als behandeling van een intra-atriale re-entry
tachycardie in patiënten met een stilstaand atrium, niet de eerste therapie van
keuze zijn. In één van onze patiënten herstelde de atriale elektrische en
mechanische functie zich gedurende follow-up. Onze resultaten suggereren
dat, hoewel het atrium elektrisch geen activiteit vertoont, -vastgesteld door de
afwezigheid van P-toppen op het oppervlakte ECG-, eilandjes van elektrische
activiteit nog steeds aanwezig kunnen zijn. Deze eilandjes kunnen bijdragen
aan re-entry circuits in het atrium.
Bekend is dat er familiair overervende vormen van deze aandoening bestaan.
Er is meer onderzoek nodig naar stilstaand atrium om meer te weten te
komen over het ontstaansmechanisme, het beloop en ook de lange termijn
prognose.
Een ander type atriale ritmestoornis wordt besproken in hoofdstuk 5. Hoewel
veel electrofysiologen de term ‘atriale tachycardie’ gebruiken, blijkt deze groep
tachycardieën te berusten op diverse pathofysiologische mechanismen. Wij
beschrijven een vorm van atriale tachycardie waarvan het mechanisme nog
niet duidelijk is. In het algemeen kan een atriale ‘automatisch focus’
tachycardie niet worden geïnduceerd in het electrofysiologisch laboratorium.
In dit hoofdstuk beschrijven wij 38 patiënten met een atriale ‘niet-automatisch
focus’ tachycardie, die wel induceerbaar was in het electrofysiologisch
laboratorium. De resultaten van deze studie laten zien dat deze vorm van
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tachycardie met name voorkomt bij vrouwen van alle leeftijdscategorieën en
dat de foci die de tachycardie veroorzaken hoofdzakelijk gelokaliseerd zijn in
het rechter atrium. Tevens blijkt dat jongere patiënten een kortere tachycardie
cycluslengte hebben dan oudere patiënten. Catheter ablatie van deze foci was
mogelijk, echter met een aanzienlijk lager succes percentage dan in het
algemeen voor de ablatie van supraventriculaire tachycardieën wordt
beschreven. Tevens hebben we catheter ablatie met behulp van een speciaal
electroanatomisch mapping systeem vergeleken met conventionele ablatie
zonder dit gespecialiseerde mapping systeem. Hoewel het aantal succesvol
geableerde foci leek te stijgen met behulp van dit mapping systeem, konden
we geen gemiddelde verkorting van de procedure- noch doorlichtingstijden
aantonen. Toekomstige studies zullen moeten uitwijzen of de gemiddelde
procedure- en doorlichtingstijd zullen afnemen al naar gelang de ervaring met
deze nieuwe mapping technieken groeit.
De introductie van nieuwe mapping systemen heeft een verdere impuls
gegeven aan de ontwikkeling van nieuwe mogelijkheden voor catheter ablatie.
Deze geavanceerde mapping systemen maken ook de meer complexe aritmie
substraten geschikt voor ablatie. In hoofdstuk 5 bespraken we het gebruik van
een electro-anatomisch mapping systeem in de ablatie van atriale ‘niet-
automatisch focus’ tachycardie. Vervolgens beschrijven we in hoofdstuk 6 het
gebruik van een ander gespecialiseerd mapping systeem, de LocaLisa, bij
ablatie van AVNRT in kinderen. Zesentwintig patiënten, onder de 19 jaar oud,
met een structureel niet afwijkend hart en symptomatische episoden van
AVNRT, ondergingen een catheter ablatie procedure. Hierbij werd een
modificatie van de ‘slow pathway’ van de AV knoop uitgevoerd. Bij alle
patiënten was de AVNRT na ablatie niet meer induceerbaar. Drie patiënten
hadden een recidief en ondergingen een tweede ablatie-procedure. Bij één kind
werd de ablatie procedure gecompliceerd door een tweede-graads AV block,
welke zes weken later spontaan weer hersteld was.
Het gebruik van het LocaLisa mapping systeem vergroot de veiligheid en
effectiviteit van slow-pathway AV knoop modificatie in jonge patiënten op
twee manieren. Ten eerste door de mogelijkheid om de afstand van iedere
potentiële radiofrequentie laesie tot de proximale bundel van His te meten.
Ten tweede doordat op het beeldscherm van de LocaLisa monitor continu de
relatie tussen de tip van de ablatie electrode ten opzichte van de AV knoop en
de bundel van His weergegeven wordt.
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Nog onduidelijk is of deze agressieve methode van ‘slow-pathway’ ablatie, in
de toekomst schadelijke effecten op de AV knoop zou kunnen hebben. Late
PQ prolongatie en zelfs AV block zijn beschreven in volwassen patiënten die
een ‘slow pathway’ modificatie van de AV knoop hebben ondergaan. Tot op de
dag van vandaag hebben wij nog geen tekenen van progressief AV block in
onze patiëntenpopulatie waargenomen.
In conclusie hebben wij in de hoofdstukken 2 tot en met 6 laten zien dat voor
de behandeling van ritmestoornissen bij kinderen, RFCA een veilige en
effectieve therapie is, die gepaard gaat met een laag complicatie risico. Daarbij
moeten we ons echter wel realiseren dat onze follow up tijd relatief kort is. Zo
is het bijvoorbeeld onbekend of littekens aangebracht door RFCA in het
onrijpe myocard, op latere leeftijd zelf een nieuw aritmogeen substraat zullen
vormen. Gezien het feit dat aan de ene kant RFCA mogelijk, veilig en effectief
lijkt te zijn in jonge patiënten, maar aan de andere kant zorgen bestaan over de
lange termijn effecten van RF lesies in het onrijpe hart, is het belangrijk dat
richtlijnen opgesteld worden. In deze richtlijnen zou duidelijk beschreven
moeten worden welke kinderen precies in aanmerking komen voor RFCA, als
alternatief voor de conventionele behandeling met anti-aritmische medicatie.
De afgelopen tien jaar hebben de indicaties voor RFCA bij kinderen zich
uitgebreid. Verantwoordelijk voor deze uitbreiding lijken onder andere de
ontwikkeling in catheter technologie, de introductie van gespecialiseerde
mapping systemen en de toenemende ervaring met RFCA voor complexe
ritmestoornis substraten. In dit kader hebben wij één vergelijkende en één
beschrijvende studie met betrekking tot gespecialiseerde mapping systemen
verricht. Echter om aan te tonen dat deze mapping systemen betere RFCA
resultaten tot gevolg hebben, zouden we een prospectief gerandomiseerde
studie moeten uitvoeren. Ethisch gezien zal dit erg moeilijk zijn om op te
zetten. Als alternatief hiervoor zouden de procedure- en doorlichtingstijden in
combinatie met de RFCA resultaten voor de verschillende ritmestoornissen,
retrospectief vergeleken kunnen worden. Zo’n onderzoeksopzet houdt echter
geen rekening met de leercurve gebonden aan de introductie van ieder nieuw
systeem. Tevens wordt hierin niet meegenomen dat bij gebruik van meer
geavanceerde mapping systemen, ook de meer complexe aritmie substraten
voor RFCA in aanmerking komen, welke dat in het verleden, vanwege hun
complexiteit niet hadden gedaan.
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BRADY-ARITMIEËN
Ook de pacemaker therapie bij kinderen heeft zich over de afgelopen tien jaar
aanzienlijk ontwikkeld. Met name de ontwikkeling van kleinere
pacemakerdraden, draden die steroïden afgeven en kleinere pacemakerkastjes,
zijn van groot belang geweest voor de vooruitgang van pacemaker therapie bij
kinderen. Hoewel bij volwassenen endocardiaal pacen uitgebreid wordt
toegepast, worden de meeste kinderen nog steeds epicardiaal gepaced. Dit
komt hoofdzakelijk omdat bij een transveneus geplaatste pacemakerdraad, de
kleine afmetingen van deze jonge patiënten een vergroot risico op veneuze
occlusie met zich meebrengen. Juist in deze patiëntengroep, waar vaak een
indicatie bestaat voor levenslange toepassing van pacemaker therapie, is men
extra voorzichtig om zodoende de bloedvaten zoveel mogelijk te behouden als
toegangsweg voor later. Dit heeft geresulteerd in de voorkeur voor een
epicardiale implantatie van pacemakers op de kinderleeftijd.
In hoofdstuk 7 beschrijven we een follow up studie van een grote serie
kinderen die een transveneuze pacemaker implantatie hebben ondergaan toen
hun lichaamsgewicht nog onder de tien kilogram was. De resultaten van deze
studie laten zien dat transveneuze pacemaker implantatie in kinderen onder de
tien kilogram mogelijk en effectief is, maar niet geheel zonder complicaties
verloopt. Negenendertig kinderen in twee centra kregen de afgelopen 15 jaar
een transveneuze pacemaker. Het overgrote deel hiervan had een ventriculaire
pacemaker gekregen voor dan wel een aangeboren compleet hartblok of
verworven compleet hartblok na chirurgie voor een aangeboren hartafwijking.
In alle gevallen werden er bij implantatie goede pacing en sensing drempels
gemeten. De follow up voor 36 patiënten van deze groep varieerde tussen de 9
maanden en 15.3 jaar (mediaan 4.3 jaar). Zestien patiënten (44%) hebben
gedurende deze hele periode nog geen enkele re-interventie ondergaan
(gemiddeld 28 maanden follow up). Tien andere patiënten (28%) ondergingen
wel een re-interventie, gemiddeld 61 maanden na implantatie, omdat de
batterij op was en de pacemaker dus vervangen moest worden. Tenslotte
ondergingen om verschillende redenen tien kinderen (28%) een re-interventie
vóórdat de batterij op was. In drie gevallen was dit omdat er problemen met
de wond van de pacemaker pocket waren. Bij vier anderen moest de
pacemakerdraad wat opgeschoven worden, omdat de patiënt zoveel gegroeid
was dat de pacemakerdraad ‘te kort’ werd.  Dit laatste probleem is inherent
aan het plaatsen van pacemakers in zeer kleine patiënten, onafhankelijk van het
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plaatsen van de pacemaker epi- of endocardiaal. Ditzelfde geldt voor de
pacemaker pocket problemen die plaatsvonden in drie patiënten. De
pacemaker pocketproblemen zouden mogelijk gedeeltelijk kunnen worden
opgelost door alle pacemaker pockets in de buik te plaatsen.
De percentages en gemiddelde follow up tijd ten tijde van re-interventie zijn
zeer acceptabel en laten zien dat transveneuze pacemaker implantatie in deze
patiëntengroep mogelijk en effectief is.
Wij vonden echter ook dat tijdens re-interventie vier asymptomatische
patiënten (11%) een occlusie hadden van het vat waar de pacemakerdraad
doorheen liep. Deze vier occlusies werden waargenomen tijdens vier van de 11
pacemakerdraad extracties en 12 pacemakerdraad opschuif procedures, die
werden verricht. Het daadwerkelijke aantal veneuze occlusies zal dus
waarschijnlijk hoger zijn, aangezien deze vier occlusies bij asymptomatische
patiënten werden gevonden, die toevallig een interventie aan de
pacemakerdraad ondergingen. Verder onderzoek is nodig naar het exacte
occlusie aantal, ook in de asymptomatische patiënten die geen interventie
ondergaan.
Om transveneus pacen in (kleine) kinderen wereldwijd meer acceptabel te
maken, zal het percentage patiënten dat een occlusie van het bloedvat
ontwikkelt, moeten dalen. Onderzocht moet worden welke patiënten in deze
gewichtscategorie een groter risico hebben om veneuze occlusie te
ontwikkelen. Het ontwikkelen van kleinere pacemakerdraden zou kunnen
bijdragen om het percentage veneuze occlusies naar beneden te brengen. Het
is ook waarschijnlijk dat nieuwe catheter technologieën, zoals het gebruik van
‘laser sheaths’, momenteel alleen bij volwassenen, ook bij kinderen in praktijk
gebracht gaan worden. Met deze technologie is het mogelijk om geoccludeerde
vaten te rekanaliseren en opnieuw te gebruiken.
ARITMIEËN NA HARTCHIRURGIE
De verbetering in uitkomsten na hartchirurgie voor aangeboren
hartafwijkingen, hebben gezorgd voor een groeiende populatie adolescenten
en volwassenen die hartchirurgie op kinderleeftijd hebben ondergaan. Deze
patiëntenpopulatie heeft zijn eigen specifieke problemen en risico’s. In de
Algemene Samenvatting en Discussie
133
follow up van chirurgisch ingrijpen voor bepaalde congenitale hartafwijkingen,
is een aanzienlijk risico voor plotselinge hartdood beschreven. Hoofdstuk 8
beschrijft een studie waarin we risicofactoren hebben bepaald voor plotselinge
hartdood na een atriale switch operatie voor transpositie van de grote vaten. In
deze studie hebben we 47 patiënten geïncludeerd die op jonge leeftijd een
atriale switch (Mustard of Senning operatie) hebben ondergaan en in follow
up plotseling overleden zijn of een ‘bijna’ plotselinge hartdood hebben
doorgemaakt. Elk van deze patiënten werd gematched met twee controle
patiënten, die dezelfde operatie hadden ondergaan, maar niet plotseling
overleden waren. Verschillende variabelen recent voor overlijden werden
verzameld en vergeleken met dezelfde informatie van de corresponderende
controles. Uit het onderzoek blijkt dat het bestaan van symptomen van
ritmestoornissen of hartfalen geassocieerd is met een verhoogd risico op
plotselinge hartdood. Daarnaast vergroot een voorgeschiedenis van
gedocumenteerde ritmestoornissen, met name supraventriculaire tachycardie,
het risico op plotselinge hartdood. Anti-aritmische medicatie noch pacemaker
implantatie hadden een beschermend effect. Deze bevindingen pleiten voor
onderzoek naar alternatieve therapieën voor het behandelen van
ritmestoornissen in deze patiëntenpopulatie. Toekomstige studies zullen
moeten uitwijzen of de verbeterde technieken van RFCA een positief effect
hebben op de behandeling van ritmestoornissen en incidentie van plotselinge
hartdood in de Mustard/Senning populatie. Aan de andere kant is de rol van
RFCA in deze patiëntenpopulatie dubieus, omdat is aangetoond dat
supraventriculaire  tachycardieën, ventriculaire disfunctie kunnen veroorzaken,
maar ook veroorzaakt kunnen worden dóór ventriculaire disfunctie. Uit het
onderzoek blijkt tevens dat zowel een thoraxfoto, als een ECG en een 24-uurs
Holter registratie geen voorspellende waarde hebben voor plotselinge
hartdood. Om risicopatiënten nauwkeuriger te definiëren is verder onderzoek
met grotere patiënten cohorten nodig. Uitgezocht moet worden of andere
testen, zoals bijvoorbeeld echocardiografie, hartcatheterisatie,
inspanningstesten en electrofysiologische testen, toevoegende waarde hebben
voor het nauwkeuriger vaststellen van het risico op plotselinge hartdood bij
patiënten met symptomen of een voorgeschiedenis van ritmestoornissen.
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Neem een moment dat je je in en in gelukkig voelt. Vanaf het balkon een
prachtig uitzicht op met sneeuw bedekte bergen, waar een schamper zonnetje
net achter schuil gaat. Op de achtergrond klinkt heel hard “Mijn leven is van
mij” (Musical Elisabeth); Dingen doen omdat je die zelf mooi vindt. Dit
boekje is daar een uitgelezen voorbeeld van.
Echter het ontstaan van dit enthousiasme, het onderhouden ervan en de
motivatie om door te gaan, ook op de momenten dat het allemaal iets minder
mooi was, heb ik te danken aan een heleboel mensen;
Prof. dr. J.J. Roord. Beste John, dat ik op jouw ‘thuis’-werkdagen op de thee, in
jouw prachtige tuin het manuscript steeds met je door kon spreken en jij
tevens van deze gelegenheden gebruik maakte om mij met wijze raad bestoken,
waardeer ik enorm. Enkele deuren van de vijf kamers zijn sindsdien weer
gesmeerd en piepen niet meer. Ik ben trots te mogen promoveren onder de
persoon die ik tevens mijn opleider mag noemen. Van het daarmee in mij
gestelde vertrouwen ben ik nog altijd onder de indruk!
Prof. dr. N. Sreeram. Beste Sreeram, mijn enthousiasme voor de
kindercardiologie heb ik absoluut aan maar één persoon te danken. Nog vers in
mijn geheugen staan de eerste maanden dat ik met jouw werkte, aan het begin
van mijn wetenschappelijke stage. Jij mij meesleurde naar de open ducti op de
NICU, echo’s op OK, naar hart-catheterisaties, het EP lab, jouw poli’s. En ook,
als ik twee jaar later even binnen stapte, altijd enthousiast, snel de mooiste en
interessantste dingen van de voorgaande weken laten zien en nog steeds bereid
om nogmaals alles van A tot Z uit te leggen. Al zou ik het willen, Sreeram, het
zou mij niet lukken dit alles te vergeten. Jouw liefde voor jouw vak, heb jij
voor de volle 100% op mij overgedragen. En daarvoor ten eerste, ben ik jou
ontzettend dankbaar! Natuurlijk was ook zonder jou dit proefschrift er nooit
geweest. Naast jouw wetenschappelijke inzichten, vaak bediscussieerd onder het
genot van een glas wijn, zijn nog meer jouw onuitputtelijke motivatie, trots,
oprechte interesse en hulp, onmisbaar geweest. Aanvankelijk als begeleider,
eindigend als promotor, altijd even menselijk; ik heb bewondering voor jou!
Tijd voor een borreltje Ledig Erf?
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Dr. S. Balaji. Dear Balaji, you have taught me criticism to the things that I am
being taught. Working with you at the OHSU has been a major contribution to
my development as a doctor, as well as to the development of this thesis. All
the times you wrote to me; ‘good work’, ‘fantastic work’ have helped me
through last summer! Besides your hospitality to let me participate in several
research projects, your hospitality at your home and family (bike and helmet
included) wasn’t less. I will never forget my first celebration of Duvali and
Christmas dinner with sprouts.
Dr. E. Rosenthal. Dear dr. Rosenthal, “dank u wel” for letting me participate in
the endocardial pacing study in Guy’s Hospital and also for your quick replies
with respect to the paper and original figures for this thesis. Tot ziens!
Alle co-auteurs, met name Carolien van Deurzen, bedankt voor jullie
enthousiasme en inzet.
Else Sreeram-de Haan. Beste Else, een woord van dank ook aan jou, voor het
uitbesteden van Sreeram aan mij, al die avonden dat hij nu juist net thuis was
uit Keulen. Jouw gastvrijheid, gezelligheid, de lekkere koffie en met name jouw
peptalks waren fantastisch.
Annette Balaji-Lovett. Dearest Annette, you are the one who has made my stay
in the US unforgettable. Your unlimited kindness, hospitality and friendship I
will never forget. We will meet one day soon again.
Cees Haaring. Beste Cees, ik heb het je al vaker gezegd, maar ik had echt niet
geweten wat ik zonder jou had gemoeten. Jouw geduld, begrip en snelle werk
hebben mij zoveel rust bezorgd. Iedereen kan wel zeggen dat het zo mooi is
om je eigen boek te lay-outen, maar ik weet zeker dat ik dit er nooit zoiets
moois van had kunnen maken.
Maarten ter Stege. Beste Maarten, samen met dit dankwoord, is jouw aandeel
waarschijnlijk het meest bekeken onderdeel van dit boek; en daarom ben ik zo
blij dat het er geweldig uitziet. Dankjewel!
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Joke de Wilde, Marieke van Oijnk, Manon Terheggen, Annemarie, Loes, Rinetta,
Nicole, Ria, Wilma, bedankt voor het gevoel altijd welkom te zijn, jullie
interesse en jullie hulp.
Lieve Troeffies, wat heerlijk om een bladzijde te wijden aan hoe blij je met
iedereen bent; jullie zijn geweldig!
Lieve Diaan, dank voor al jouw steun, trots en medeleven. Vanaf jaar 1, en nu
weer: “We” zijn begonnen. Handstand op het Neude? Pisa wacht op ons…
You’re simply the best!
Mijn allerbeste paranimfen, ik kan niet beschrijven hoe bijzonder ik het vind
dat jullie deze dag naast mij willen staan;
Lieve Mart, jouw onvermoeibaar luisterend oor, statistiekboeken…,
opbeurende woorden, winkelacties en relax-avondjes, jouw betrokkenheid,
jouw zenuwen zelfs in de Pyreneeën, the No. 1 down south, goede ideeën, vele
sms-jes, telefoontjes, nog meer gezelligheid en dan… ligt hier eindelijk voor je:
Het boekje. Weer eens naborrelen? Dank je lieve Mart, mooi dat je er vandaag
weer bij zult zijn!
Lieve Rik, een aantal behoorlijke ‘projecten’ heb ik met jou de afgelopen jaren
volbracht. Na lubben op de Amsterdamse Straatweg en vele gezamenlijke
financiële lunches vind ik het geweldig dat je ook dit project nog met mij aan
wil pakken!
Lieve Eem, we hebben het er al veel vaker over gehad, dat juist de mensen die
zo dichtbij je staan, het altijd mogen ontgelden op de momenten dat het
allemaal iets minder lekker loopt… Toch ben jij degene die onvoorwaardelijk
je best bleef doen, klaar stond om mij te helpen en altijd even belde op het
goeie moment. Lieve Eem, ik ben zo ontzettend blij met en trots op mijn
zusje!
Lieve Ruud, ik weet nog heel goed dat jij in de vijfde klas van de middelbare
school tegen mij zei: “ik vind het allemaal wel mooi wat je doet, maar jij bent
altijd zo druk”. En moet je jezelf nu eens kijken? Lieve grote broer, als ik één
iemand zou moeten noemen die ik het allerliefste vaker zou speken dan dat ik
nu doe, ben jij dat. Het wordt nu absoluut ‘wat minder druk’; tijd voor een
date binnenkort?
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Lieve pap en mam, een zeer speciale dank is gericht aan jullie. Heel goed
realiseer ik me dat het door jullie is, dat ik werkelijk altijd heb kunnen doen
wat ik wilde. Ook als het naar jullie mening niet het allerbeste plan was.
Hoewel ik achteraf weet, dat in heel veel dingen jullie tóch gelijk hadden,
gingen jullie altijd volledig achter mijn keuzes staan. Dank voor jullie
betrokkenheid, support, liefde en trots en dat jullie naar Portland kwamen.
Liefste paps en mams, ik ben zo gelukkig dat juist jullie mijn ouders zijn!
Liefste Robbie, jij hebt geen idee hoe ontzettend veel jij hebt bijgedragen aan de
afronding van dit boekje. Fijn hè, dat je nu eindelijk tijd krijgt om aan je eigen
project te beginnen… Hoop dat ik enigszins kan evenaren wat jij hierin voor
mij betekend hebt. Dankjewel voor al jouw oneindig geduld, steun,
enthousiasme, trots en interesse. “Mijn leven is van mij”, maar om dat met
jouw te delen, is het aller-allermooiste!
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De auteur van dit proefschrift werd op 7 maart 1977 geboren in Gouda. De
middelbare schooltijd werd doorgebracht op het Coornhert Gymnasium in
deze zelfde stad. Na het behalen van het diploma in 1995, startte zij met de
studie geneeskunde in Utrecht. Het doctoraal examen werd behaald in
augustus 2000. Tijdens haar studententijd was zij naast diverse student-
assistentschappen, actief als voorzitter van een gala-commisie en
penningmeester van het bestuur van de medische faculteitsvereniging.
Voor haar wetenschappelijke stage werkte zij aan verschillende
onderzoeksprojecten bij de afdeling kindercardiologie van het Wilhelmina
Kinderziekenhuis te Utrecht, onder begeleiding van Prof. dr. N. Sreeram. Naast
onderzoek kreeg zij deze stage ook de kans om de kliniek en interventies van
de kindercardiologie van dichtbij te bekijken. Wachttijd voor de co-schappen
bood een mooie gelegenheid om ditzelfde vak ook in een andere kliniek, in
een ander land te zien. Verschillende nieuwe onderzoeksprojecten werden
uitgedacht en vervolgens onder begeleiding van dr. S. Balaji, gedurende zeven
maanden uitgevoerd bij de afdeling kindercardiologie van de Oregon Health &
Sciences University in Portland, Oregon, Verenigde Staten. Na deze periode van
onderzoek gecombineerd met avondskiën, woestijn-, strand-, vulkaan en
stedentripjes, liepen een aantal interessante studies. Op het moment dat de co-
schappen aanvingen waren deze projecten nog niet geheel ‘afgerond ’. Toen het
einde van de co-schappen naderde, kreeg zij de kans om het grootste deel van
deze studies in één boekje te publiceren. Na een laatste keuze co-schap bij de
kindercardiologie van het Sophia kinderziekenhuis - Erasmus MC te
Rotterdam, behaalde zij in april 2003 het artsexamen. Per oktober 2003 kon zij
beginnen met haar opleiding kindergeneeskunde, aanvangend met de perifere
stage van de opleiding in de Stichting Deventer Ziekenhuizen, te Deventer
(opleider drs. C.A. Ultee).

Lijst van publicaties
145
Hoorntje T, Kammeraad J, Bennink GBWE, Sreeram N. Transvenous
permanent pacemaker implantation in neonates. Int J Cardiol 2000; 75: 103-4.
Schulze OC, Kammeraad J, Ramanna H,  Sreeram N. Catheter ablation for
tachyarrhythmia-induced cardiomyopathy in infants. Int J Cardiol 2000; 74: 99-100.
Kammeraad J, Hoorntje TM, Ramanna H, vDriel V, Wittkampf FHM, Hauer
RNW, Derksen R, Robles de Medina EO, Sreeram N. Catheter ablation of
tachyarrhythmia substrates in children. Cardiologie 2000; 7: 412-6.
Kammeraad J, Ramanna H, Sreeram N. Ablatie van een atriumflutter bij een
tweejarig kind met partieel stilstaand atrium. Cardiologie 2000; 7: 437-40.
Kammeraad JAE, Balaji S, Oliver RP, Chugh SS, Halperin BD, Kron J, McAnulty
JH. Non-automatic focal atrial tachycardia: characterization and ablation of a
poorly understood arrhythmia in 38 patients. PACE 2003; 26: 736-42.
Kammeraad J, Ramanna H, Sreeram N. Ablation of atrial reentrant tachycardia
in children with silent atrium. Int J Cardiol 2003; 89: 91-92.
Kammeraad JAE, Balaji S, van Driel V, Oliver RP, Sreeram N. Is routine
echocardiography valuable after uncomplicated catheter ablation in children?
Accepted for publication in Cardiol Young.
Kammeraad JAE, Rosenthal E, Bostock J, Rogers J, Sreeram N. Endocardial
pacemaker implantation in infants d” 10 kg bodyweight. Accepted for
publication in PACE.
Kammeraad JAE, Udink ten Cate FEA, Wittkampf FHM, Sreeram N.
Radiofrequency catheter ablation of atrioventricular nodal reentrant
tachycardia in children using a novel mapping system. Accepted for publication
in Europace.
Udink ten Cate FEA, Kammeraad JAE, Witsenburg M, Sreeram N. Het sluiten
van een ventrikel septum defect met percutane hartcatheterisatie. In Press, Ned
Tijdschr Geneeskd.
Kammeraad JAE, v Deurzen CHM, Sreeram N, Bink-Boelkens MTH,
Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S.
Predictors of sudden cardiac death after Mustard or Senning repair for
transposition of the great arteries. Accepted for publication in J Am Coll
Cardiol.

